var title_f39_54_40800="Traction retinal detachment";
var content_f39_54_40800=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F71858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F71858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Traction retinal detachment: Appearance on fundus photograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 333px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Color fundus photograph of traction retinal detachment due to contraction of neovascularization with prominent associated fibrous tissue; there are numerous striae indicating tractional retinal elevation of the macula and fovea to the left of the disc.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40800=[""].join("\n");
var outline_f39_54_40800=null;
var title_f39_54_40801="Pelvic lymphadenectomy3";
var content_f39_54_40801=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Expose the obturator nerve under the obturator node bundle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40801=[""].join("\n");
var outline_f39_54_40801=null;
var title_f39_54_40802="Pathogenesis and clinical manifestations of struvite stones";
var content_f39_54_40802=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and clinical manifestations of struvite stones",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40802/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40802/contributors\">",
"     Glenn M Preminger, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40802/contributors\">",
"     Gary C Curhan, MD, ScD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40802/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40802/contributors\">",
"     Stanley Goldfarb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40802/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40802/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/54/40802/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Struvite stones may grow rapidly over a period of weeks to months and, if not adequately treated, can develop into a staghorn or branched calculus that fills the entire intra-renal collecting system. A review of the pathogenesis and clinical manifestations of struvite stones will be presented here. The management of these stones is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/18/40231?source=see_link\">",
"     \"Management of struvite or staghorn calculi\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Struvite stones are composed of magnesium ammonium phosphate (struvite) and calcium carbonate-apatite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40802/abstract/1\">",
"     1",
"    </a>",
"    ]. Normal urine is undersaturated with ammonium phosphate, and struvite stone formation occurs only when ammonia production is increased and the urine pH is elevated to decrease the solubility of phosphate. The only situation in which this occurs in humans is with an upper urinary tract infection with a urease-producing organism, such as Proteus or Klebsiella. Urease breaks down urinary urea into ammonia plus carbon dioxide:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;Urea &nbsp; &nbsp;&mdash;&gt; &nbsp; &nbsp;2NH3 &nbsp; + &nbsp; CO2",
"   </p>",
"   <p>",
"    The ammonia produced by this reaction then combines with water:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;NH3 &nbsp; + &nbsp; H2O &nbsp; &nbsp;&mdash;&gt; &nbsp; &nbsp;NH4+ &nbsp; + &nbsp; OH-",
"   </p>",
"   <p>",
"    The net result is increased availability of ammonium in an alkaline urine. This is in contrast to the usual setting of increased ammonium due to increased acid production and low urine pH.",
"   </p>",
"   <p>",
"    In comparison to those patients with pure struvite stones, many men and some women have mixed calcium and struvite stones. It is presumed that the primary event in this setting is calcium oxalate stone formation, with secondary infection and struvite deposition. In these patients, a comprehensive medical evaluation will uncover the underlying metabolic defect(s) responsible for calcium stone formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40802/abstract/2\">",
"     2",
"    </a>",
"    ]. Alternatively, patients with pure struvite stones will not benefit from a metabolic evaluation but would benefit from a determination of the cause of the recurrent upper tract infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10451471\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of struvite stone formation is, in part, gender-dependent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40802/abstract/3\">",
"     3",
"    </a>",
"    ]. Women are more likely to form pure struvite stones (3:1) because females are more likely to develop an upper urinary tract infection. Other patients susceptible to infection, such as those with a neurogenic bladder or a urinary diversion, also may form pure struvite stones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40802/abstract/4\">",
"     4",
"    </a>",
"    ]. In France, the prevalence of struvite stones has not changed over the past three decades [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40802/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, improving care of patients at high risk for infection has shifted the epidemiology of stones in such patients. As an example, in a cohort of 33 immobile patients with musculoskeletal anomalies (traditionally at high risk for struvite stones), the proportion of stones due to infection was only 18 percent; the rest were calcium or uric acid stones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40802/abstract/6\">",
"     6",
"    </a>",
"    ]. In addition, a 2011 study of 52 patients with staghorn calculi revealed that just 44 percent were struvite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40802/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H90635667\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms directly attributable to struvite stones are uncommon. More often, patients will present with symptoms of a urinary tract infection, mild flank pain, or hematuria and will be found to have a persistently alkaline urine pH (&gt;7.0), often with multiple magnesium ammonium phosphate crystals in the urine sediment (",
"    <a class=\"graphic graphic_picture graphicRef54594 \" href=\"mobipreview.htm?34/38/35439\">",
"     picture 1",
"    </a>",
"    ), and a complex renal calculus on plain film of the abdomen. The stone may grow rapidly over a period of weeks to months and, if not adequately treated (including complete removal and treatment of the infection), can develop into a staghorn or branched calculus filling the entire renal pelvis and calyces (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62009 \" href=\"mobipreview.htm?42/7/43123\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72669 \" href=\"mobipreview.htm?20/47/21233\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Persistent infection within the stone often leads to focal areas of parenchymal scarring with loss of cortex (chronic pyelonephritis). Passage of a struvite stone is rare. When passed and collected or removed surgically, chemical analysis of these stones may falsely report the absence of struvite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40802/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Thus, if the suspicion is high in the appropriate clinical setting, struvite may be present even if not identified by the analyzing laboratory.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H90635554\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Struvite stones are composed of magnesium ammonium phosphate (struvite) and calcium carbonate-apatite. Such stones only form in the setting of an upper urinary tract infection with urea-splitting bacteria, such as Proteus or Klebsiella. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women are more likely to form pure struvite stones than men (3:1) because females are more likely to develop an upper urinary tract infection. Other patients susceptible to infection, such as those with a neurogenic bladder or a urinary diversion, also may form pure struvite stones. (See",
"      <a class=\"local\" href=\"#H10451471\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms directly attributable to struvite stones are uncommon. Most frequently, patients will present with symptoms of a urinary tract infection, mild flank pain, or hematuria. The stone may grow rapidly over a period of weeks to months and, if not adequately treated, can develop into a staghorn or branched calculus filling the entire renal pelvis and calyces. (See",
"      <a class=\"local\" href=\"#H90635667\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40802/abstract/1\">",
"      Griffith DP. Struvite stones. Kidney Int 1978; 13:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40802/abstract/2\">",
"      Lingeman JE, Siegel YI, Steele B. Metabolic evaluation of infected renal lithiasis: clinical relevance. J Endourol 1995; 9:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40802/abstract/3\">",
"      Kristensen C, Parks JH, Lindheimer M, Coe FL. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int 1987; 32:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40802/abstract/4\">",
"      Kaefer M, Hendren WH, Bauer SB, et al. Reservoir calculi: a comparison of reservoirs constructed from stomach and other enteric segments. J Urol 1998; 160:2187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40802/abstract/5\">",
"      Daudon M, Bouzidi H, Bazin D. Composition and morphology of phosphate stones and their relation with etiology. Urol Res 2010; 38:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40802/abstract/6\">",
"      Gnessin E, Mandeville JA, Handa SE, Lingeman JE. Changing composition of renal calculi in patients with musculoskeletal anomalies. J Endourol 2011; 25:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40802/abstract/7\">",
"      Viprakasit DP, Sawyer MD, Herrell SD, Miller NL. Changing composition of staghorn calculi. J Urol 2011; 186:2285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40802/abstract/8\">",
"      Krambeck AE, Lingeman JE, McAteer JA, Williams JC Jr. Analysis of mixed stones is prone to error: a study with US laboratories using micro CT for verification of sample content. Urol Res 2010; 38:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40802/abstract/9\">",
"      Krambeck AE, Khan NF, Jackson ME, et al. Inaccurate reporting of mineral composition by commercial stone analysis laboratories: implications for infection and metabolic stones. J Urol 2010; 184:1543.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7372 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-A590A08E48-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40802=[""].join("\n");
var outline_f39_54_40802=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H90635554\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10451471\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H90635667\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H90635554\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7372\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7372|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?42/7/43123\" title=\"diagnostic image 1\">",
"      KUB showing staghorn calculi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?20/47/21233\" title=\"diagnostic image 2\">",
"      CT scan showing large renal pelvic stone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7372|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/38/35439\" title=\"picture 1\">",
"      Struvite crystals",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/18/40231?source=related_link\">",
"      Management of struvite or staghorn calculi",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_54_40803="Aspirin and cardiovascular disease";
var content_f39_54_40803=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Aspirin and cardiovascular disease (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/54/40803/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40803/contributors\" id=\"au7318\">",
"       Charles H Hennekens, MD, DrPH",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/54/40803/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40803/contributors\" id=\"se4323\">",
"       Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/54/40803/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40803/contributors\" id=\"de1101\">",
"       Gordon M Saperia, MD, FACC",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?39/54/40803?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ASPIRIN AND HEART DISEASE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Aspirin is a nonsteroidal antiinflammatory drug (NSAID) that has been used at moderate to high doses to decrease pain and reduce swelling. More recently, low dose aspirin has been used to treat and prevent cardiovascular disease (CVD).",
"    </p>",
"    <p>",
"     Cardiovascular disease includes conditions such as heart attack, stroke, and peripheral artery disease (poor circulation) in the legs; these conditions cause more than 900,000 deaths each year in the United States alone.",
"    </p>",
"    <p>",
"     Many large trials have shown that aspirin has benefits for the following groups:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Virtually all people who have had a heart attack, stroke, or peripheral artery disease, as well as angina, stents, or bypass surgery",
"      </li>",
"      <li>",
"       Men and women who have no signs or symptoms but have an increased risk of a first heart attack (eg, due to diabetes or other risk factors)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     However, the benefits of aspirin must be weighed against its possible side effects. People with a higher risk of heart attack have a greater potential for benefit. Thus, it is important to discuss the overall risk of cardiovascular disease with a healthcare provider to determine if aspirin could be of benefit.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      ACTIONS OF ASPIRIN",
"     </span>",
"    </p>",
"    <p>",
"     Aspirin inhibits the clumping of platelets (even in low doses), has pain killing effects (in medium doses), and has antiinflammatory effects (in high doses).",
"    </p>",
"    <p>",
"     Platelets are tiny cell fragments circulating in the blood that have a role in blood clotting. Under normal circumstances, platelets clump together and help form blood clots that stop bleeding. However, in coronary heart disease, platelets clump together in narrowed arteries, which leads to the development of a clot within the artery; the platelet \"plug\" itself",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     the clot that forms can block blood flow (",
"     <a class=\"graphic graphic_figure graphicRef60394 \" href=\"mobipreview.htm?3/16/3331\">",
"      figure 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     This blockage can have significant consequences. When the arteries that supply blood to the brain are blocked, the supply of oxygen to the brain is decreased. The consequences of this depend upon the duration and the extent to which blood flow is cut off.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       When the arteries that supply blood and oxygen to the heart are blocked briefly, the result is an episode of chest pain, called",
"       <strong>",
"        angina",
"       </strong>",
"       . A blockage that is of longer duration can result in a",
"       <strong>",
"        heart attack",
"       </strong>",
"       (also called myocardial infarction).",
"      </li>",
"      <li>",
"       In the brain, when the blockage is brief, the result is a",
"       <strong>",
"        transient ischemic attack",
"       </strong>",
"       (TIA), and when the blockage is longer, the result is an ischemic",
"       <strong>",
"        stroke",
"       </strong>",
"       . (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/37/38484?source=see_link\">",
"        \"Patient information: Stroke symptoms and diagnosis (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      BENEFITS OF ASPIRIN",
"     </span>",
"    </p>",
"    <p>",
"     The benefits of aspirin have been studied in a wide range of patients, including the groups discussed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Prevention of heart attack or stroke",
"     </span>",
"     &nbsp;&mdash;&nbsp;Several large trials, primarily among men, have shown that aspirin can prevent a first heart attack in people who have no signs or symptoms of cardiovascular disease (this is called primary prevention). However, these trials could not detect the effects of aspirin on the risk of stroke and death related to cardiovascular disease. In one trial of women, aspirin reduced the risk of a first stroke and also decreased the risk of a first heart attack among those 65 years and over [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/54/40803/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     The risk of a first heart attack or stroke in healthy men and women is far lower than among those who are having or have had an event. As a result, the benefit of reducing the risk of a first heart attack must be weighed against risks, such as gastrointestinal bleeding and other side effects. (See",
"     <a class=\"local\" href=\"#H9\">",
"      'Side effects of aspirin'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     Expert groups recommend aspirin to prevent heart attack or stroke for healthy men and women when the benefits outweigh the risks; this includes people with a 10-year risk of a coronary event of at least 6 to 10 percent. The 10-year risk can be calculated here for women (",
"     <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/19/15679?source=see_link\">",
"      calculator 1",
"     </a>",
"     ) and for men (",
"     <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/14/15599?source=see_link\">",
"      calculator 2",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     For healthy men and women at low risk of a first event, the benefit of aspirin (prevention of heart attacks or strokes) is similar to the risk of harm (gastrointestinal bleeding). Thus, it is important to discuss your absolute benefits of aspirin on a first heart attack or stroke and your risks of aspirin with your healthcare provider.",
"    </p>",
"    <p>",
"     The recommended daily dose of aspirin for prevention of heart attack and stroke is between 81 mg and 162.5 mg.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      During a heart attack",
"     </span>",
"     &nbsp;&mdash;&nbsp;Aspirin can be life-saving for people who are actively having a heart attack. Healthcare providers recommend that anyone who believes they may be having a heart attack immediately take 162 to 325 mg of plain aspirin (one half to one whole adult aspirin tablet). If only enteric coated aspirin is available then the pill should be crushed or chewed to obtain an immediate effect. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/16/40195?source=see_link\">",
"      \"Patient information: Heart attack (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      After coronary events",
"     </span>",
"     &nbsp;&mdash;&nbsp;Aspirin is recommended for people who have a history of the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Heart attack",
"      </li>",
"      <li>",
"       Stable or unstable angina",
"      </li>",
"      <li>",
"       Coronary bypass graft surgery or percutaneous coronary intervention (angioplasty)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=see_link\">",
"      \"Patient information: Heart attack recovery (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/16/23813?source=see_link\">",
"      \"Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/38/18020?source=see_link\">",
"      \"Patient information: Heart stents and angioplasty (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Most healthcare providers recommend that people in this group take between 75 and 100 mg of aspirin daily.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      During and after stroke",
"     </span>",
"     &nbsp;&mdash;&nbsp;Aspirin has benefits in people who are having or have recently had an ischemic stroke or transient ischemic attack (TIA). The recommended dose for this group is 162.5 to 325 mg during and 81 to 325 mg per day after stroke. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/53/19286?source=see_link\">",
"      \"Patient information: Ischemic stroke treatment (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?20/18/20772?source=see_link\">",
"      \"Patient information: Transient ischemic attack (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Aspirin plus clopidogrel",
"     </span>",
"     &nbsp;&mdash;&nbsp;Another antiplatelet medication (clopidogrel, Plavix&reg;) may be recommended, in addition to aspirin, to further reduce the risk of future heart attacks and strokes. This may be suggested for people with a high risk of future cardiovascular events, including people with a prior heart attack, ischemic stroke, or symptomatic peripheral artery disease (also called claudication). (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/35/14900?source=see_link\">",
"      \"Patient information: Peripheral artery disease and claudication (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      SIDE EFFECTS OF ASPIRIN",
"     </span>",
"    </p>",
"    <p>",
"     Aspirin can have a significant benefit for people with a wide range of blockages in the heart, brain, or peripheral arteries, as well as those without prior events but who have a sufficiently high risk. However, aspirin has two main side effects: stomach upset (nausea, vomiting, heartburn, stomach pain, or ulcers) and bleeding.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Stomach upset",
"     </span>",
"     &nbsp;&mdash;&nbsp;In one large study, approximately 4 percent of all people who took 300 mg of aspirin daily for 5 years noted stomach upset. Signs and symptoms of ulcer were far less common, although the risk of ulcers (particularly bleeding ulcers) is increased in the following settings:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Increasing age, particularly &gt;60 years",
"      </li>",
"      <li>",
"       Higher doses of aspirin",
"      </li>",
"      <li>",
"       Long duration of aspirin use",
"      </li>",
"      <li>",
"       A past history of gastrointestinal complications from aspirin or other NSAIDs (ibuprofen or naprosyn)",
"      </li>",
"      <li>",
"       A past history of ulcers (see",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/60/964?source=see_link\">",
"        \"Patient information: Peptic ulcer disease (Beyond the Basics)\"",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Current use of steroids (eg, prednisone), anticoagulants (such as warfarin), or other NSAIDs",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     To help prevent stomach upset, aspirin should be taken with food. People with a history of ulcers or stomach upset while taking aspirin or other NSAIDs should talk with a healthcare provider before starting; several recommendations can be made, depending upon the particular circumstances:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       The dose may be reduced",
"      </li>",
"      <li>",
"       An enteric-coated (EC) or buffered formulation may be recommended",
"      </li>",
"      <li>",
"       A medication may be given to reduce stomach acid",
"      </li>",
"      <li>",
"       Testing for a microorganism called H. pylori, which can cause ulcers, may be done (see",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/58/14242?source=see_link\">",
"        \"Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)\"",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     For patients who cannot tolerate aspirin, other antiplatelet medications, especially (clopidogrel [Plavix&reg;] but also ticlopidine [Ticlid&reg;]) are available. In certain circumstances , an oral anticoagulant (blood-thinning) drug, such as warfarin (Coumadin&reg;), may be recommended in addition to or as an alternative to aspirin. The risks of bleeding are further increased when another antiplatelet agent or an anticoagulant are added to aspirin. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/15/21747?source=see_link\">",
"      \"Patient information: Warfarin (Coumadin) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Bleeding",
"     </span>",
"     &nbsp;&mdash;&nbsp;Individuals who take aspirin regularly may bleed more than usual after a cut or a nose-bleed. This type of bleeding usually causes no significant problems. Of bigger concern is when bleeding occurs in other areas, most commonly in the gastrointestinal tract (such as a bleeding ulcer), or extremely rarely, in the brain (hemorrhagic stroke). For these reasons, the benefits of aspirin must be weighed against the risks.",
"    </p>",
"    <p>",
"     Because the effects of aspirin on bleeding last for about a week, it is important to notify a healthcare provider or dentist about aspirin use before any surgery or procedure. In most cases, aspirin should be stopped 7 to 10 days before a scheduled surgery or procedure.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Interaction with ibuprofen",
"     </span>",
"     &nbsp;&mdash;&nbsp;As mentioned above, taking aspirin and another NSAID (such as ibuprofen) at the same time can increase the likelihood of stomach upset. There is also some evidence that therapy with ibuprofen can interfere with the ability of aspirin to stop platelets from sticking together. For these reasons it seems prudent to take aspirin at least two hours before ibuprofen.",
"    </p>",
"    <p>",
"     There is also some evidence that therapy with ibuprofen can interfere with the protective effect of aspirin on cardiovascular disease. Patients should speak to a healthcare provider about this interaction if they require long-term ibuprofen therapy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      IS ASPIRIN RIGHT FOR ME?",
"     </span>",
"    </p>",
"    <p>",
"     You and your healthcare provider must balance the benefits of aspirin against the potential risks. As general rules:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Aspirin has a clear benefit in people with a current or past history of heart attack, angina, ischemic stroke, transient ischemic attack, peripheral artery disease (claudication), as well as people with a 10-year risk of having a coronary event of at least 6 to 10 percent. The 10-year risk can be calculated here for women (",
"       <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/19/15679?source=see_link\">",
"        calculator 1",
"       </a>",
"       ) and for men (",
"       <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/14/15599?source=see_link\">",
"        calculator 2",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       Aspirin is likely to have a benefit in people with a moderate to high risk of heart attack or ischemic stroke (stroke caused by blockage of arteries that supply blood to the brain).",
"      </li>",
"      <li>",
"       The benefits of aspirin may not outweigh the risks in people who have a low risk of heart attack or ischemic stroke.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804496844\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21385872\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/37/36435?source=see_link\">",
"      Patient information: Medicines after an ischemic stroke (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/27/21940?source=see_link\">",
"      Patient information: Medicines after a heart attack (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/10/27809?source=see_link\">",
"      Patient information: Coronary heart disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/6/37987?source=see_link\">",
"      Patient information: Heart attack recovery (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?38/40/39554?source=see_link\">",
"      Patient information: Lowering the risk of having another stroke (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21385880\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/37/38484?source=see_link\">",
"      Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/16/40195?source=see_link\">",
"      Patient information: Heart attack (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=see_link\">",
"      Patient information: Heart attack recovery (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/16/23813?source=see_link\">",
"      Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/38/18020?source=see_link\">",
"      Patient information: Heart stents and angioplasty (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/53/19286?source=see_link\">",
"      Patient information: Ischemic stroke treatment (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?20/18/20772?source=see_link\">",
"      Patient information: Transient ischemic attack (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/35/14900?source=see_link\">",
"      Patient information: Peripheral artery disease and claudication (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/60/964?source=see_link\">",
"      Patient information: Peptic ulcer disease (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/58/14242?source=see_link\">",
"      Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/15/21747?source=see_link\">",
"      Patient information: Warfarin (Coumadin) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/47/2807?source=see_link\">",
"      Aspirin: Mechanism of action, major toxicities, and use in rheumatic diseases",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37066?source=see_link\">",
"      Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/28/5576?source=see_link\">",
"      Overview of primary prevention of coronary heart disease and stroke",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40906?source=see_link\">",
"      Secondary prevention of cardiovascular disease",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Heart, Lung, and Blood Institute",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nhlbi.nih.gov/\">",
"      www.nhlbi.nih.gov/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Heart Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.americanheart.org/\">",
"      www.americanheart.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The National Coalition for Women with Heart Disease",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.womenheart.org/\">",
"      www.womenheart.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/54/40803/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 25, 2008.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?39/54/40803?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40803/abstract/1\">",
"      Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40803/abstract/2\">",
"      Becker RC, Meade TW, Berger PB, et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:776S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40803/abstract/3\">",
"      Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373:1849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40803/abstract/4\">",
"      Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50:e1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f39_54_40803=[""].join("\n");
var outline_f39_54_40803=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ASPIRIN AND HEART DISEASE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           ACTIONS OF ASPIRIN",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           BENEFITS OF ASPIRIN",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           SIDE EFFECTS OF ASPIRIN",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           IS ASPIRIN RIGHT FOR ME?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/16/3331\" title=\"figure 1\">",
"           Plaque rupture MI PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        CALCULATORS",
"       </h1>",
"       <div id=\"relatedCalculators\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/19/15679?source=related_link\" title=\"calculator 1\">",
"           Calculator: 10 year risk of developing cardiovascular disease in women (Patient information)",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/14/15599?source=related_link\" title=\"calculator 2\">",
"           Calculator: 10 year risk of developing cardiovascular disease in men (Patient information)",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f39_54_40804="Abdomen anatomy adult PI";
var content_f39_54_40804=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F64960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F64960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Organs inside the abdomen (belly)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40804=[""].join("\n");
var outline_f39_54_40804=null;
var title_f39_54_40805="Effects of anesthesia and surgery on the liver";
var content_f39_54_40805=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Effects of anesthesia and surgery on the liver",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40805/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40805/contributors\">",
"     Lawrence S Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40805/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40805/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40805/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40805/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/54/40805/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of anesthesia and surgery on the liver depend upon the type of anesthesia used, the specific surgical procedures, and the severity of liver disease. In addition, perioperative events, such as hypotension, sepsis, or the administration of hepatotoxic drugs, can compound injury to the liver occurring during the procedure.",
"   </p>",
"   <p>",
"    This topic review will summarize the influence of these factors, while an overall approach to assessment of the risk of surgery in patients with liver disease is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12858?source=see_link\">",
"     \"Assessing surgical risk in patients with liver disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MILD VERSUS CLINICALLY APPARENT LIVER DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild elevations in serum aminotransferase, alkaline phosphatase, or bilirubin concentrations are common following surgical procedures regardless of the type of anesthesia used, and they usually resolve without further consequences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinically important hepatic dysfunction is uncommon, but is much more likely in patients with preexisting liver disease. A review of 733 patients with cirrhosis who underwent surgery at the Mayo Clinic found a perioperative mortality rate of 11.6 percent and a complication rate of 30 percent, which is much higher than would be expected for a population without liver disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/3\">",
"     3",
"    </a>",
"    ]. A number of risk factors for mortality or complications were identified including a high Child-Pugh score, the presence of ascites, an elevated serum creatinine concentration, preoperative upper gastrointestinal bleeding, and a high American Society of Anesthesiologists physical status rating (",
"    <a class=\"graphic graphic_table graphicRef78084 \" href=\"mobipreview.htm?9/5/9307\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TYPE OF SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The type of surgery is probably the most important determinant of postoperative hepatic dysfunction in patients with liver disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/4\">",
"     4",
"    </a>",
"    ]. The following are general principles:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Laparotomy is associated with a greater reduction in hepatic arterial blood flow than extra-abdominal surgery, in part because traction on the abdominal viscera can cause reflex systemic hypotension due to dilatation of capacitance vessels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/5,6\">",
"       5,6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Procedures associated with a large amount of blood loss increase the risk of ischemic hepatic injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with cirrhosis who have had prior abdominal surgery can have highly vascular adhesions surrounding the liver, which can bleed excessively during surgery.",
"     </li>",
"     <li>",
"      Emergency surgery is associated with higher morbidity and mortality than elective surgery.",
"     </li>",
"     <li>",
"      Cholecystectomy, gastric surgery, and colectomy have been associated with particularly high mortality rates in patients with decompensated cirrhosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/8-17\">",
"       8-17",
"      </a>",
"      ]. More recent data suggest that the outcome of cholecystectomy has improved. A MELD score (see below) of &ge;8 was associated with increased 30- and 90-day morbidity rates in one study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/18\">",
"       18",
"      </a>",
"      ]. In selected cases of patients with compensated cirrhosis, a laparoscopic approach may be feasible [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. Nevertheless, less invasive options, such as cholecystostomy, should be considered, especially in patients with advanced cirrhosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/9/15511?source=see_link\">",
"       \"Treatment of acute cholecystitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cardiac surgery in patients with cirrhosis is also associated with a high mortality [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/21\">",
"       21",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12858?source=see_link&amp;anchor=H14#H14\">",
"       \"Assessing surgical risk in patients with liver disease\", section on 'Cardiac surgery'",
"      </a>",
"      .)&nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     HEMODYNAMIC EFFECTS OF ANESTHESIA ON THE LIVER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies on healthy patients have demonstrated that the effects of general anesthesia on the hepatic circulation are variable. As a general rule, most inhalation anesthetics are associated with reductions in portal blood flow and cardiac output [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/22\">",
"     22",
"    </a>",
"    ]. The effect on hepatic arterial blood flow depends upon the specific anesthetic used and the type of operation. As examples, the volatile anesthetics halothane and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/47/34548?source=see_link\">",
"     enflurane",
"    </a>",
"    reduce hepatic arterial blood flow because of systemic vasodilatation and a slightly negative inotropic effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/1,23,24\">",
"     1,23,24",
"    </a>",
"    ], while",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/63/17397?source=see_link\">",
"     isoflurane",
"    </a>",
"    increases or has a neutral effect on hepatic arterial blood flow, and has therefore been preferred in patients with liver disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/25\">",
"     25",
"    </a>",
"    ]. Because most of the blood supply to the liver is provided by the portal vein, the net effect of these hemodynamic changes is usually to decrease hepatic blood flow and oxygen delivery.",
"   </p>",
"   <p>",
"    The degree to which these changes take place in patients with advanced liver disease has not been well studied in humans. Such patients have a number of baseline circulatory abnormalities, including an increased cardiac index and decreased systemic vascular resistance, which could influence hepatic blood flow during anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. In an animal model of cirrhosis, the increased cardiac index was maintained during general anesthesia and was associated with increased portal venous inflow compared to controls, suggesting that the hyperdynamic circulation in cirrhosis might protect against hepatic hypoperfusion during general anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/29\">",
"     29",
"    </a>",
"    ]. On the other hand, patients with cirrhosis may be more sensitive to hepatic hypoperfusion relative to baseline conditions. As a result, they may be more susceptible to liver injury, particularly if they are faced with additional insults to the liver (such as administration of a hepatotoxic drug or the development of infection).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HEPATIC METABOLISM OF INHALED ANESTHETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anesthetic agents are capable of producing hepatotoxicity by a variety of mechanisms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/63/29690?source=see_link\">",
"     \"Drugs and the liver: Patterns of drug-induced liver injury\"",
"    </a>",
"    .) As a general rule, the degree of hepatic metabolism correlates with the likelihood of a toxic reaction.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/63/17397?source=see_link\">",
"     Isoflurane",
"    </a>",
"    and the newer haloalkanes (ie,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/44/5830?source=see_link\">",
"     desflurane",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/47/23286?source=see_link\">",
"     sevoflurane",
"    </a>",
"    ) undergo less hepatic metabolism than halothane or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/47/34548?source=see_link\">",
"     enflurane",
"    </a>",
"    (0.2 percent for isoflurane, 20 percent for halothane, and 2 to 4 percent for enflurane), and have been associated with the lowest risk of hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/1,30,31\">",
"     1,30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of the currently used haloalkanes, halothane has been associated with the greatest risk of hepatotoxicity. The incidence of fulminant hepatitis following halothane exposure is approximately 1 in 6000 to 1 in 35,000 following a single exposure, and increases to about 1 in 3000 following multiple exposures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Other risk factors for severe hepatotoxicity include female gender, age greater than 50, and obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34871?source=see_link\">",
"     \"Halothane hepatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Concern about hepatotoxicity has virtually eliminated the use of halothane in adults in the United States. However, halothane toxicity has not been reported in children. Because it is highly potent and has a tolerable odor, halothane continues to be used widely for the induction of anesthesia in children in the United States. Furthermore, halothane is possibly the most commonly used inhalational anesthetic in all patients worldwide.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     MECHANICAL VENTILATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with liver disease commonly have respiratory compromise due to a number of causes either directly related to the liver disease (such as hepatopulmonary syndrome, pleural effusions, pulmonary hypertension) or because of associated conditions such as COPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/3,34\">",
"     3,34",
"    </a>",
"    ]. Severe hypoxemia (p02 &lt;60 mmHg) is usually considered to be a relative contraindication to surgery (except for liver transplantation in patients with hepatopulmonary syndrome), but is fortunately uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/35/3640?source=see_link\">",
"     \"Hepatopulmonary syndrome: Prevalence, causes, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypercarbia should be avoided in patients with liver disease during mechanical ventilation since it initiates sympathetic stimulation of the splanchnic vasculature, thereby decreasing portal blood flow. Patients with advanced liver disease usually have a mild compensated respiratory alkalosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/36\">",
"     36",
"    </a>",
"    ]. Thus, the pCO2 should be maintained in the range of 35 to 40 mmHg during surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/25\">",
"     25",
"    </a>",
"    ]. A higher-than-usual concentration of oxygen during anesthesia has also been recommended for patients with cirrhosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     NEUROMUSCULAR BLOCKING AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuromuscular blocking agents may contribute to the changes in liver blood flow during general anesthesia discussed above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/37\">",
"     37",
"    </a>",
"    ]. Furthermore, their effects may be prolonged in patients with liver disease because of decreased biliary excretion, reduced plasma pseudocholinesterase activity, and an increase in volume of distribution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/14/6374?source=see_link\">",
"     Atracurium",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/1/26646?source=see_link\">",
"     cisatracurium",
"    </a>",
"    are favored for patients with liver disease or biliary obstruction because their metabolism does not depend upon the liver or kidneys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/25,40\">",
"     25,40",
"    </a>",
"    ]. Doxacurium (a long-acting, nondepolarizing muscle relaxant) is recommended for prolonged surgical procedures such as liver transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ANALGESICS AND SEDATIVES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shorter acting analgesics and sedatives are preferred in patients with liver disease since longer acting agents increase the risk of postoperative delirium and hepatic encephalopathy. The effects of liver disease on the metabolism of these drugs is variable. As an example, although the metabolism of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/63/1015?source=see_link\">",
"     thiopental",
"    </a>",
"    is decreased in patients with cirrhosis, plasma protein binding is also decreased so that total body clearance is unaltered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with liver disease have an increased risk for rare hepatotoxic reactions to benzodiazepines or barbiturates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40805/abstract/43\">",
"     43",
"    </a>",
"    ]. The pattern of injury is usually cholestatic and sometimes includes a syndrome of fever, hepatitis, lymphadenopathy, eosinophilia, and dermatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The type of surgery is probably the most important determinant of postoperative hepatic dysfunction in patients with liver disease. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Type of surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anesthetic agents are capable of producing hepatotoxicity by a variety of mechanisms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/63/29690?source=see_link\">",
"       \"Drugs and the liver: Patterns of drug-induced liver injury\"",
"      </a>",
"      .) As a general rule, the degree of hepatic metabolism correlates with the likelihood of a toxic reaction. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Hepatic metabolism of inhaled anesthetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neuromuscular blocking agents may contribute to the changes in liver blood flow during general anesthesia. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Neuromuscular blocking agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Shorter acting analgesics and sedatives are preferred in patients with liver disease since longer acting agents increase the risk of postoperative delirium and hepatic encephalopathy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Analgesics and sedatives'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Strunin L. Anesthetic management of patients with liver disease. In: Wright's Liver and Biliary Disease, Millward-Sadler GH, Wright R, Arthur MJ (Eds), Saunders, London 1992. p.1381.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/2\">",
"      Clarke RS, Doggart JR, Lavery T. Changes in liver function after different types of surgery. Br J Anaesth 1976; 48:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/3\">",
"      Ziser A, Plevak DJ, Wiesner RH, et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999; 90:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/4\">",
"      Friedman LS, Maddrey WC. Surgery in the patient with liver disease. Med Clin North Am 1987; 71:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/5\">",
"      Gelman SI. Disturbances in hepatic blood flow during anesthesia and surgery. Arch Surg 1976; 111:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/6\">",
"      TORRANCE HB. Liver blood flow during operations on the upper abdomen. J R Coll Surg Edinb 1957; 2:216.",
"     </a>",
"    </li>",
"    <li>",
"     Rosenberg PM, Friedman LS. The liver in circulatory failure. In: Schiff's Diseases of the Liver, 8th ed, Schiff ER, Sorrell MF, Maddrey WC (Eds), Lippincott-Raven, Philadelphia 1999. p.1215.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/8\">",
"      Bloch RS, Allaben RD, Walt AJ. Cholecystectomy in patients with cirrhosis. A surgical challenge. Arch Surg 1985; 120:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/9\">",
"      Aranha GV, Sontag SJ, Greenlee HB. Cholecystectomy in cirrhotic patients: a formidable operation. Am J Surg 1982; 143:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/10\">",
"      Aranha GV, Kruss D, Greenlee HB. Therapeutic options for biliary tract disease in advanced cirrhosis. Am J Surg 1988; 155:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/11\">",
"      Castaing D, Houssin D, Lemoine J, Bismuth H. Surgical management of gallstones in cirrhotic patients. Am J Surg 1983; 146:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/12\">",
"      Schwartz SI. Biliary tract surgery and cirrhosis: a critical combination. Surgery 1981; 90:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/13\">",
"      McSherry CK, Glenn F. The incidence and causes of death following surgery for nonmalignant biliary tract disease. Ann Surg 1980; 191:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/14\">",
"      Pitt HA, Cameron JL, Postier RG, Gadacz TR. Factors affecting mortality in biliary tract surgery. Am J Surg 1981; 141:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/15\">",
"      Lehnert T, Herfarth C. Peptic ulcer surgery in patients with liver cirrhosis. Ann Surg 1993; 217:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/16\">",
"      Metcalf AM, Dozois RR, Wolff BG, Beart RW Jr. The surgical risk of colectomy in patients with cirrhosis. Dis Colon Rectum 1987; 30:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/17\">",
"      Meunier K, Mucci S, Quentin V, et al. Colorectal surgery in cirrhotic patients: assessment of operative morbidity and mortality. Dis Colon Rectum 2008; 51:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/18\">",
"      Perkins L, Jeffries M, Patel T. Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol 2004; 2:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/19\">",
"      Fernandes NF, Schwesinger WH, Hilsenbeck SG, et al. Laparoscopic cholecystectomy and cirrhosis: a case-control study of outcomes. Liver Transpl 2000; 6:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/20\">",
"      Poggio JL, Rowland CM, Gores GJ, et al. A comparison of laparoscopic and open cholecystectomy in patients with compensated cirrhosis and symptomatic gallstone disease. Surgery 2000; 127:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/21\">",
"      Klemperer JD, Ko W, Krieger KH, et al. Cardiac operations in patients with cirrhosis. Ann Thorac Surg 1998; 65:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/22\">",
"      Gelman S. General anesthesia and hepatic circulation. Can J Physiol Pharmacol 1987; 65:1762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/23\">",
"      Batchelder BM, Cooperman LH. Effects of anesthetics on splanchnic circulation and metabolism. Surg Clin North Am 1975; 55:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/24\">",
"      Ngai SH. Effects of anesthetics on various organs. N Engl J Med 1980; 302:564.",
"     </a>",
"    </li>",
"    <li>",
"     Maze M. Anesthesia and the liver. In: Anesthesia, 4th ed, Miller RD (Ed), Churchill Livingstone, Edinburgh 1994. p.1969.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/26\">",
"      KONTOS HA, SHAPIRO W, MAUCK HP, PATTERSON JL Jr. GENERAL AND REGIONAL CIRCULATORY ALTERATIONS IN CIRRHOSIS OF THE LIVER. Am J Med 1964; 37:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/27\">",
"      MURRAY JF, DAWSON AM, SHERLOCK S. Circulatory changes in chronic liver disease. Am J Med 1958; 24:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/28\">",
"      Benoit J, Womack W, Korthuis R, et al. Chronic portal hypertension: Effects on gastrointestinal blood flow distribution. Am J Physiol 1986; 251:G535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/29\">",
"      Hori N, Okanoue T, Sawa Y, et al. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration. Dig Dis Sci 1993; 38:2195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/30\">",
"      Kenna JG. Immunoallergic drug-induced hepatitis: lessons from halothane. J Hepatol 1997; 26 Suppl 1:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/31\">",
"      Berghaus TM, Baron A, Geier A, et al. Hepatotoxicity following desflurane anesthesia. Hepatology 1999; 29:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/32\">",
"      Walton B, Simpson BR, Strunin L, et al. Unexplained hepatitis following halothane. Br Med J 1976; 1:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/33\">",
"      Gut J. Molecular basis of halothane hepatitis. Arch Toxicol Suppl 1998; 20:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/34\">",
"      King PD, Rumbaut R, Sanchez C. Pulmonary manifestations of chronic liver disease. Dig Dis 1996; 14:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/35\">",
"      M&oslash;ller S, Hillings&oslash; J, Christensen E, Henriksen JH. Arterial hypoxaemia in cirrhosis: fact or fiction? Gut 1998; 42:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/36\">",
"      Moreau R, Hadengue A, Soupison T, et al. Arterial and mixed venous acid-base status in patients with cirrhosis. Influence of liver failure. Liver 1993; 13:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/37\">",
"      Cowan RE, Jackson BT, Grainger SL, Thompson RP. Effects of anesthetic agents and abdominal surgery on liver blood flow. Hepatology 1991; 14:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/38\">",
"      Green DW, Fisher M, Sockalingham I. Mivacurium compared with succinylcholine in children with liver disease. Br J Anaesth 1998; 81:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/39\">",
"      Magorian T, Wood P, Caldwell J, et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg 1995; 80:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/40\">",
"      Parker CJ, Hunter JM. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis. Br J Anaesth 1989; 62:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/41\">",
"      Hunter JM. New neuromuscular blocking drugs. N Engl J Med 1995; 332:1691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40805/abstract/42\">",
"      Pandele G, Chaux F, Salvadori C, et al. Thiopental pharmacokinetics in patients with cirrhosis. Anesthesiology 1983; 59:123.",
"     </a>",
"    </li>",
"    <li>",
"     Farrell GC. Drug-Induced Liver Disease, Churchill Livingstone, Edinburgh 1994.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1243 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-125.39.66.150-9E46D5F071-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40805=[""].join("\n");
var outline_f39_54_40805=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MILD VERSUS CLINICALLY APPARENT LIVER DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TYPE OF SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HEMODYNAMIC EFFECTS OF ANESTHESIA ON THE LIVER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HEPATIC METABOLISM OF INHALED ANESTHETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      MECHANICAL VENTILATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      NEUROMUSCULAR BLOCKING AGENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ANALGESICS AND SEDATIVES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/1243\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1243|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/5/9307\" title=\"table 1\">",
"      ASA physical status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12858?source=related_link\">",
"      Assessing surgical risk in patients with liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/63/29690?source=related_link\">",
"      Drugs and the liver: Patterns of drug-induced liver injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34871?source=related_link\">",
"      Halothane hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/35/3640?source=related_link\">",
"      Hepatopulmonary syndrome: Prevalence, causes, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/9/15511?source=related_link\">",
"      Treatment of acute cholecystitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_54_40806="Infiltrating lobular carcinoma of the breast";
var content_f39_54_40806=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F54150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F54150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 607px\">",
"   <div class=\"ttl\">",
"    Infiltrating lobular carcinoma of the breast",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 587px; height: 227px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Panel A) Low power view of an infiltrating lobular breast carcinoma shows small tumor cells that infiltrate the stroma singly and in a single file pattern.",
"    <br/>",
"    (Panel B) High power view demonstrates that the tumor cells are relatively small and uniform in appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stuart Schnitt, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40806=[""].join("\n");
var outline_f39_54_40806=null;
var title_f39_54_40807="Esoph CA squamous Light";
var content_f39_54_40807=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68324&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68324&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Squamous cell esophageal cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low-power photomicrograph shows a well-differentiated invasive squamous esophageal cancer on the left adjacent to normal squamous epithelium on the right. The tumor contains keratin \"pearls\" (arrows) that are characteristic features of well-differentiated squamous cell carcinomas. In addition, the invading nests of malignant squamous cells exhibit a characteristic irregular configuration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the American Gastroenterological Association&copy;. This slide cannot be downloaded but may be purchased as part of a set from the AGA through Milner- Fenwick, Inc. at 1-800-432-8433.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40807=[""].join("\n");
var outline_f39_54_40807=null;
var title_f39_54_40808="Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment";
var content_f39_54_40808=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40808/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40808/contributors\">",
"     David T Scadden, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40808/contributors\">",
"     Andrew R Freedman, FRCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40808/contributors\">",
"     Paul Robertson, MRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40808/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40808/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40808/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40808/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/54/40808/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The human T-lymphotropic virus type I (HTLV-I) is a retrovirus that infects 10 to 20 million people worldwide, as estimated by seroprevalence studies. However, HTLV-I is associated with disease in only approximately 5 percent of infected individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis and treatment of HTLV-I infection and what is known about the disease associations will be reviewed here. The virology, pathogenesis, and epidemiology of HTLV-I are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/48/5897?source=see_link\">",
"     \"Human T-lymphotropic virus type I: Virology, pathogenesis, and epidemiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DISEASE ASSOCIATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of HTLV-I-infected individuals will remain asymptomatic, but there are two well-recognized disease associations caused by the virus:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Adult T cell leukemia-lymphoma (ATL)",
"     </li>",
"     <li>",
"      HTLV-I-associated myelopathy (HAM), also known as tropical spastic paraparesis (TSP).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, several other clinical entities have been described in infected patients (",
"    <a class=\"graphic graphic_table graphicRef66919 \" href=\"mobipreview.htm?7/48/7947\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Adult T cell leukemia-lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;HTLV-I was first isolated from a patient with a cutaneous T cell lymphoma in 1980 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/3\">",
"     3",
"    </a>",
"    ]. Since then it has become clear that the cumulative lifetime risk of ATL in a patient with HTLV-I infection is between 2 and 5 percent. The risk is slightly higher in males; the onset of ATL is typically delayed for 20 to 30 years after the viral infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9945?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of adult T cell leukemia-lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ATL is characterized by clonal proliferation of CD4+ T cells containing randomly integrated HTLV-I provirus, often associated with T cell receptor gene rearrangements. These cells have a distinct morphology with indented nuclei containing condensed chromatin and basophilic cytoplasm (",
"    <a class=\"graphic graphic_picture graphicRef72646 \" href=\"mobipreview.htm?4/40/4736\">",
"     picture 1",
"    </a>",
"    ). Four distinct clinical forms of ATL are recognized [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Acute",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute ATL accounts for 47 to 57 percent of cases and follows an aggressive course with a median survival of six months. Clinical features include: skin lesions (nodules, ulcers, generalized papular rash), lytic bone lesions, hypercalcemia, and pulmonary infiltrates. The latter may be due either to direct leukemic infiltration or to opportunistic infections such as Pneumocystis jirovecii (formerly carinii) pneumonia (PCP) resulting from AIDS-like immunodeficiency. Central nervous system (CNS) involvement occurs in up to 10 percent of cases. Laboratory findings include raised levels of lactate dehydrogenase and alkaline phosphatase as well as hypercalcemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Lymphomatous",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lymphomatous form of ATL occurs in approximately 20 to 25 percent of cases. The clinical features include lymphadenopathy, hepatosplenomegaly, and skin lesions. Hypercalcemia is also common, but circulating tumor cells are unusual.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Chronic",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chronic form, which accounts for 20 percent of cases, has a better prognosis with a median survival of approximately two years. Hypercalcemia does not occur, and there is no CNS or gastrointestinal involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Smoldering",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoldering ATL is the least common type (approximately 5 percent of cases); median survival is more than five years. Skin and pulmonary lesions do occur, but other clinical features such as lymphadenopathy, hepatosplenomegaly, and hypercalcemia are absent. Less than 5 percent of peripheral CD4+ cells are involved, with proviral DNA integrated in a monoclonal fashion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Markers of disease progression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several serum markers have been found to be elevated, especially in the acute form of ATL. These include serum CD25 (interleukin-2 receptor), serum thymidine kinase activity, and serum neuron-specific enolase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. Investigators have proposed that CD25 and enolase, the levels of which are highly correlated, may serve as markers of disease progression and might be monitored during treatment. However, these tests are not currently used in clinical practice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of standard regimens for advanced, aggressive non-Hodgkin lymphoma (NHL) is moderately effective, with most patients achieving initial partial or complete remission. However, early relapse is usual and median survival is only eight months.",
"   </p>",
"   <p>",
"    A phase III trial comparing biweekly CHOP with a more aggressive chemotherapeutic regimen of VCAP (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/29/1498?source=see_link\">",
"     vincristine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    ) plus AMP (doxorubicin, ranimustine, and prednisone) plus VECP (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31123?source=see_link\">",
"     vindesine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    , and prednisone) in 118 Japanese patients demonstrated significantly higher complete response rates with the more aggressive regimen (40 percent versus 25 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/9\">",
"     9",
"    </a>",
"    ]. However, overall survival at three years was similar and toxicity-related morbidity and death was greater in the aggressive chemotherapy arm. Thus, the use of intensive combination chemotherapy remains investigational.",
"   </p>",
"   <p>",
"    Allogeneic stem cell transplantation has been reported to benefit some patients already in remission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/10\">",
"     10",
"    </a>",
"    ]. A combination of the nucleoside reverse transcriptase inhibitor (NRTI),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    (ZDV), plus interferon (IFN)-alpha was found to be effective in the short term [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chemotherapy for ATL is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/36/30281?source=see_link\">",
"     \"Treatment and prognosis of adult T cell leukemia-lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     HTLV-I-associated myelopathy/tropical spastic paraparesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the first clinical description of TSP was published from the Caribbean in 1956 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/12\">",
"     12",
"    </a>",
"    ], it was not until 1985 that investigators reported the association of this condition with antibodies to HTLV-I in serum and cerebrospinal fluid (CSF) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. A group in Japan called the condition HAM in 1986 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/15\">",
"     15",
"    </a>",
"    ], but it was soon realized that TSP and HAM were the same",
"    <span class=\"nowrap\">",
"     entities.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;HAM/TSP",
"    is more common in females than males, in keeping with the higher prevalence of HTLV-I infection in females. It affects less than 2 percent of HTLV-I carriers, with onset ranging from four months to 30 years (median 3.3 years) after infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/16\">",
"     16",
"    </a>",
"    ]. In another prospective cohort analysis, HTLV-1-associated myelopathy was found in 3.7 percent (95% CI 1.4-8.0) and HTLV-II myelopathy in 1.0 percent (95% CI 0.3-2.5) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk factors for developing",
"    <span class=\"nowrap\">",
"     HAM/TSP",
"    </span>",
"    are not well understood. One important risk factor appears to be a high provirus load [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition, certain polymorphisms in the interleukin (IL)-10 promoter and in the IL28B gene, which is involved in interferon lambda expression, may be associated with both provirus load and the risk of",
"    <span class=\"nowrap\">",
"     HAM/TSP",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The illness is characterized by an insidious onset of slowly progressive weakness and spasticity of one or both legs, together with hyperreflexia, ankle clonus, extensor plantar responses, and lumbar pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Other features include back pain, detrusor instability leading to nocturia, urinary frequency, incontinence, and minor sensory changes, especially paresthesias and loss of vibration sense [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/23\">",
"     23",
"    </a>",
"    ]. Cognitive function is unaffected and there is no upper limb involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic criteria were agreed upon by a World Health Organization (WHO) panel in 1989 (",
"    <a class=\"graphic graphic_table graphicRef77037 \" href=\"mobipreview.htm?37/29/38364\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/24\">",
"     24",
"    </a>",
"    ]. In addition to the laboratory diagnostic tests listed in table 2, the use of HTLV-1 proviral load in the central nervous system (CNS) has been proposed as a new parameter for diagnosis of",
"    <span class=\"nowrap\">",
"     HAM/TSP",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Magnetic resonance imaging of the brain and spinal cord may be normal or may show atrophy of the cervical or thoracic cord",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    white matter lesions in the subcortical and periventricular regions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Cerebrospinal fluid (CSF) examination reveals a low level lymphocytosis in approximately one-third of cases as well as a mildly elevated protein concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/28\">",
"     28",
"    </a>",
"    ]. Anti-HTLV-I antibodies are detectable in the CSF with a high",
"    <span class=\"nowrap\">",
"     CSF/serum",
"    </span>",
"    ratio. Virus can be cultured from CSF lymphocytes and proviral DNA detected by PCR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/29\">",
"     29",
"    </a>",
"    ]. Neurophysiologic studies may reveal evidence of posterior column dysfunction as well as a peripheral neuropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiviral therapy has not been shown to be effective in the treatment of",
"    <span class=\"nowrap\">",
"     HAM/TSP.",
"    </span>",
"    However, corticosteroids, presumably through their anti-inflammatory effect, have been reported to slow progression in one case series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/30\">",
"     30",
"    </a>",
"    ], and reduce neurologic disability in another [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/31\">",
"     31",
"    </a>",
"    ]. However, others have reported no such benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/27,32\">",
"     27,32",
"    </a>",
"    ] and there have been no randomized clinical trials. The anabolic steroid",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/0/26629?source=see_link\">",
"     danazol",
"    </a>",
"    was also demonstrated to be beneficial in one small study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/33\">",
"     33",
"    </a>",
"    ]. In addition, a small open-label trial of interferon-beta1a has demonstrated benefit in both clinical and immunologic parameters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a study of 123 patients with a 14-year follow-up,",
"    <span class=\"nowrap\">",
"     HAM/TSP",
"    </span>",
"    was demonstrated to progress from disease onset to wheelchair confinement over a median of 21 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prospective cohort study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/17\">",
"     17",
"    </a>",
"    ], which included 160 patients with HTLV-I, revealed six cases of",
"    <span class=\"nowrap\">",
"     HAM/TSP",
"    </span>",
"    diagnosed over a 12-year period (as well as a further four cases in 405 subjects with HTLV-II infection). Clinical progression was highly variable in this small cohort. The most severely affected subjects were wheelchair bound, while patients with mild cases only experienced difficulty rising from a chair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other disease manifestations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other neurological abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to myelopathy, HTLV-1 infection is also associated with other neurological abnormalities, including isolated mild cognitive deficits, peripheral neuropathy, neurogenic bladder dysfunction, and amyotrophic lateral sclerosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/36\">",
"     36",
"    </a>",
"    ]. In one study of 606 HTLV-1 infected individuals in Brazil, HTLV-1 proviral loads in patients with these neurologic manifestations were significantly higher than in asymptomatic carriers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/37\">",
"     37",
"    </a>",
"    ]. Another study found that HTLV-1 and HTLV-II infected patients were more likely than seronegative controls to have symptoms of leg weakness, impaired tandem gait, and urinary incontinence as well as physical examination findings of Babinski sign and impaired vibration sense [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Infective dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infective dermatitis was first described in Jamaica in 1966 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/39\">",
"     39",
"    </a>",
"    ]. Subsequently, its association with HTLV-I infection was recognized in several endemic areas, including Japan and the Caribbean [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. The onset is usually in early childhood, and the condition tends to improve with age. In a series of 42 cases from Brazil, the mean age of onset was 2.6 years (range 2 months to 11 years), with skin lesions appearing during the first year of life in about one-third of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/42\">",
"     42",
"    </a>",
"    ]. Remission occurred in 36 percent of cases, at a mean age of 15 years.",
"   </p>",
"   <p>",
"    It is characterized by an eczematous, exudative rash affecting the scalp, postauricular region, face, axillae and groins. This may be associated with nasal involvement, including watery discharge and crusting of the anterior nares, and dermatopathic lymphadenopathy. Although the condition is caused primarily by HTLV-1 infection, secondary infection with Staphylococcus aureus or beta-hemolytic streptococci is common. Consequently, it usually responds well to antibiotics but tends to relapse upon stopping therapy.",
"   </p>",
"   <p>",
"    In the Brazilian case series, almost one-half of the patients who had long-term follow-up were also ultimately diagnosed with HTLV-associated",
"    <span class=\"nowrap\">",
"     myelopathy/tropical",
"    </span>",
"    spastic paraparesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'HTLV-I-associated myelopathy/tropical spastic paraparesis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Uveitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association of HTLV-I infection with uveitis was first reported in Japan in 1989 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/43\">",
"     43",
"    </a>",
"    ]. It is more common in younger patients with HTLV-I (under the age of 50) and slightly more frequent in females, but its exact incidence among HTLV-I carriers remains uncertain. The condition presents with visual disturbance, including floaters and blurred or \"foggy\" vision, and is bilateral in nearly half of those affected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/44\">",
"     44",
"    </a>",
"    ]. Ocular signs include: iritis, vitreous opacities, retinal vasculitis and retinal hemorrhages and exudates. There is a good response to topical or systemic corticosteroids but relapse is common upon discontinuation of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Rheumatologic and pulmonary disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of rheumatologic conditions have been described in association with HTLV-I infection. A chronic inflammatory arthropathy has been reported in some patients, affecting predominantly the shoulders, wrists, and knees [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/45\">",
"     45",
"    </a>",
"    ]. Synovial biopsy from involved joints reveals synovial cell proliferation together with lymphocytic infiltration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sj&ouml;gren's syndrome has been described in a group of HTLV-I-infected patients with and without",
"    <span class=\"nowrap\">",
"     HAM/TSP",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/46\">",
"     46",
"    </a>",
"    ]. Clinical features were similar to those seen in HTLV-I-negative Sj&ouml;gren's and included dry eyes and mouth, ocular signs, and histologic evidence of glandular involvement. Some patients also had other autoimmune features such as arthropathy, Raynaud's, and interstitial pneumonitis.",
"   </p>",
"   <p>",
"    Investigators in Jamaica reported HTLV-I positivity in 11 of 13 patients presenting with polymyositis and concluded that there was likely to be a causative relationship [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A lymphocytic alveolitis was first reported in 1987 in five Japanese patients with",
"    <span class=\"nowrap\">",
"     HAM/TSP",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/48\">",
"     48",
"    </a>",
"    ]. Subsequent studies from Japan have also described radiographic and pathologic findings consistent with a lymphocytic bronchiolitis associated with HTLV-1 infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/49-53\">",
"     49-53",
"    </a>",
"    ]. However, since these features may be found in asymptomatic patients, their clinical significance remains uncertain.",
"   </p>",
"   <p>",
"    Indigenous Australians have one of the highest prevalence rates of bronchiectasis in the world. One prospective study among indigenous Australians found a very high seroprevalence of HTLV type 1 among hospitalized patients with bronchiectasis (nearly 60 percent) compared with historical background HTLV-1 prevalence rates (7 to 14 percent), suggesting that HTLV-1 infection may contribute to the risk of developing this pulmonary disease in this population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Immune thrombocytopenia (ITP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;HTLV-I infection was found in 17 (22.1 percent) of 77 Japanese patients with ITP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/55\">",
"     55",
"    </a>",
"    ]. Response to steroid treatment was poor and five patients required splenectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Gastric cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some epidemiologic data suggest that the incidence of gastric cancer may be lower in patients with HTLV-1 infection. For example, the incidence of gastric cancer is lower in Kamigoto compared with Nagasaki, Japan; in contrast the rate of HTLV-1 positivity in Kamigoto is high (30 percent among age groups at risk for gastric cancer) compared with other areas in Japan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/56\">",
"     56",
"    </a>",
"    ]. Some reports have also noted a low prevalence of Helicobacter pylori infection among patients infected with HTLV-1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective cohort study was performed in 5686 patients aged &gt;40 years in Kamigoto to assess the relationship between serologic evidence of HTLV-1 infection, H. pylori infection, and the subsequent development of gastric cancer over a decade of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/56\">",
"     56",
"    </a>",
"    ]. HTLV-1 infection was associated with a reduced risk of H. pylori infection and a lower risk of gastric cancer (OR, 0.38; 95% CI, 0.21-0.70).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of HTLV-I infection is generally based upon serologic testing to detect antibodies to the virus. An enzyme-linked immunosorbent assay (ELISA) is the most frequently used screening test, using antigens prepared from whole virus lysate or by recombinant technology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/58\">",
"     58",
"    </a>",
"    ]. Particle agglutination is an alternative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/59\">",
"     59",
"    </a>",
"    ]. Western blotting (WB) is normally used for confirmatory testing, which requires detection of antibodies to both gag and env viral gene products. WB also distinguishes between infection with HTLV-I and the less pathogenic HTLV-II [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/48/5897?source=see_link\">",
"     \"Human T-lymphotropic virus type I: Virology, pathogenesis, and epidemiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some individuals with a positive screening ELISA test may have an indeterminate Western blot test, with incomplete antibody reactivity to HTLV-I antigens. The clinical significance of this finding is unclear, but may reflect prior exposure, cross-reactivity to other infectious agents, or infection with a novel retrovirus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Polymerase chain reaction (PCR)-based testing to detect proviral DNA in peripheral blood mononuclear cells is an alternative diagnostic test. This test will also differentiate HTLV-I from HTLV-II infection. Advantages of this type of analysis are its ability to provide quantitation of proviral load in the blood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/62\">",
"     62",
"    </a>",
"    ], and its applicability in detecting proviral DNA in tumor cells or other tissue samples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     TREATMENT AND PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been only limited studies of specific antiretroviral therapy for HTLV-I infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/64\">",
"     64",
"    </a>",
"    ]. As noted above, the combination of the nucleoside analogue reverse transcriptase inhibitor (NRTI) ZDV, with IFN-alpha, has been used with some benefit in patients with ATL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/11,65\">",
"     11,65",
"    </a>",
"    ]. However, it is unclear whether the ZDV activity relates to its antiviral effect or to direct cytotoxicity.",
"   </p>",
"   <p>",
"    The data on",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/7/38007?source=see_link\">",
"     lamivudine",
"    </a>",
"    (3TC), another NRTI, are mixed with some in vitro and in vivo benefits noted, despite an apparent absence of antiviral activity. In one study, 3TC inhibited long-term growth of HTLV-I-infected peripheral blood mononuclear cells despite a lack of antiviral activity at clinically relevant concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/66\">",
"     66",
"    </a>",
"    ]. Another report demonstrated HTLV-I resistance in its reverse transcriptase to 3TC but not to four other NRTIs (ZDV,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    [ddI],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/45/43734?source=see_link\">",
"     stavudine",
"    </a>",
"    [d4T], and zalcitabine [ddC]) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/67\">",
"     67",
"    </a>",
"    ]. 3TC has been administered alone and in combination to a few HTLV-I-infected patients with mixed results.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two patients with",
"      <span class=\"nowrap\">",
"       HAM/TSP",
"      </span>",
"      were treated with 3TC plus ZDV; one patient had a 2-log reduction in proviral load after three months, which was sustained, but she did not experience neurologic improvement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/68\">",
"       68",
"      </a>",
"      ]. The second patient had a 1-log increase in proviral load.",
"     </li>",
"     <li>",
"      A randomized, double blind, placebo-controlled study of six months combination therapy with 3TC and ZDV in 16 patients with HAM showed no significant differences in clinical parameters or proviral load between treatment and placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A series of five patients with",
"      <span class=\"nowrap\">",
"       HAM/TSP",
"      </span>",
"      who received 3TC alone documented an approximate 10-fold decline in HTLV-I DNA initially followed by fluctuations between baseline and the lowest point thereafter [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment is",
"    <strong>",
"     not",
"    </strong>",
"    indicated for asymptomatic individuals, and management is confined to the early diagnosis of clinical manifestations and to the prevention of transmission to others. The latter includes avoidance of breast-feeding in endemic areas, screening of blood donors, as well as the promotion of safe sex and discouraging needle sharing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40808/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/48/5897?source=see_link\">",
"     \"Human T-lymphotropic virus type I: Virology, pathogenesis, and epidemiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The human T-lymphotropic virus (HTLV-I) is a retrovirus, which infects 10 to 20 million people worldwide, but is associated with disease in only approximately 5 percent of individuals. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two well-recognized disease associations are caused by the virus: Adult T cell leukemia-lymphoma (ATL) and HTLV-I-associated myelopathy (HAM), also known as tropical spastic paraparesis (TSP). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Disease associations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Four distinct clinical forms of ATL are recognized: acute, lymphomatous, chronic, and smoldering. These various forms of disease have varying presentations and prognosis. The most common clinical presentation is acute ATL, which has the poorest overall survival of approximately six months. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Adult T cell leukemia-lymphoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HTLV-I associated",
"      <span class=\"nowrap\">",
"       myelopathy/tropical",
"      </span>",
"      spastic paraparesis is characterized by an insidious onset of slowly progressive weakness and spasticity of one or both legs, together with hyperreflexia, ankle clonus, extensor plantar responses, and lumbar pain. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'HTLV-I-associated myelopathy/tropical spastic paraparesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other disease manifestations include neuropathy, infiltrative skin disorders, uveitis, and rheumatologic and pulmonary disorders. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Other disease manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of HTLV-I infection is generally based upon serologic testing with ELISA followed by a confirmatory Western blot test. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No therapy is of proven benefit in",
"      <span class=\"nowrap\">",
"       HAM/TSP",
"      </span>",
"      but corticosteroids may slow progression and reduce disability. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'HTLV-I-associated myelopathy/tropical spastic paraparesis'",
"      </a>",
"      above.) Treatment of ATL is discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/36/30281?source=see_link\">",
"       \"Treatment and prognosis of adult T cell leukemia-lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treatment is not indicated for asymptomatic HTLV-1 infection. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Treatment and prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/1\">",
"      Kaplan JE, Osame M, Kubota H, et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990; 3:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/2\">",
"      Cleghorn FR, Manns A, Falk R, et al. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J Natl Cancer Inst 1995; 87:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/3\">",
"      Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980; 77:7415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/4\">",
"      Kondo T, Kono H, Miyamoto N, et al. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer 1989; 43:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/5\">",
"      Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/6\">",
"      Kamihira S, Atogami S, Sohda H, et al. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 1994; 73:2753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/7\">",
"      Araki K, Harada K, Nakamoto K, et al. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers. Clin Exp Immunol 2000; 119:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/8\">",
"      Fujiwara H, Arima N, Ohtsubo H, et al. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia. Am J Hematol 2002; 71:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/9\">",
"      Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007; 25:5458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/10\">",
"      Obama K, Tara M, Sao H, et al. Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia. Int J Hematol 1999; 69:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/11\">",
"      Gill PS, Harrington W Jr, Kaplan MH, et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995; 332:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/12\">",
"      CRUICKSHANK EK. A neuropathic syndrome of uncertain origin; review of 100 cases. West Indian Med J 1956; 5:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/13\">",
"      Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/14\">",
"      Gessain A, Francis H, Sonan T, et al. HTLV-I and tropical spastic paraparesis in Africa. Lancet 1986; 2:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/15\">",
"      Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/16\">",
"      Maloney EM, Cleghorn FR, Morgan OS, et al. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/17\">",
"      Orland JR, Engstrom J, Fridey J, et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 2003; 61:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/18\">",
"      Yoshida M, Osame M, Kawai H, et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 1989; 26:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/19\">",
"      Sabouri AH, Saito M, Lloyd AL, et al. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2004; 190:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/20\">",
"      Trevi&ntilde;o A, Lopez M, Vispo E, et al. Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms. Clin Infect Dis 2012; 55:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/21\">",
"      Nakagawa M, Izumo S, Ijichi S, et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1995; 1:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/22\">",
"      Gotuzzo E, Cabrera J, Deza L, et al. Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin Infect Dis 2004; 39:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/23\">",
"      Castro NM, Rodrigues W Jr, Freitas DM, et al. Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers. Urology 2007; 69:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/24\">",
"      WHO. Virus diseases: Human T lymphotropic virus type I, HTLV-I. Wkly Epidemiol Rec 1989; 64:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/25\">",
"      Lezin A, Olindo S, Oliere S, et al. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis? J Infect Dis 2005; 191:1830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/26\">",
"      Melo A, Moura L, Rios S, et al. Magnetic resonance imaging in HTLV-I associated myelopathy. Arq Neuropsiquiatr 1993; 51:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/27\">",
"      Kira J, Fujihara K, Itoyama Y, et al. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci 1991; 106:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/28\">",
"      Milagres AC, Jorge ML, Marchiori PE, Segurado AA. Human T cell lymphotropic virus type 1-associated myelopathy in S&atilde;o Paulo, Brazil. Epidemiologic and clinical features of a university hospital cohort. Neuroepidemiology 2002; 21:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/29\">",
"      Takenouchi N, Yamano Y, Usuku K, et al. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 2003; 9:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/30\">",
"      Nakagawa M, Nakahara K, Maruyama Y, et al. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis. J Neurovirol 1996; 2:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/31\">",
"      Croda MG, de Oliveira AC, Vergara MP, et al. Corticosteroid therapy in TSP/HAM patients: the results from a 10 years open cohort. J Neurol Sci 2008; 269:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/32\">",
"      Ara&uacute;jo AQ, Afonso CR, Leite AC, Dultra SV. Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). Arq Neuropsiquiatr 1993; 51:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/33\">",
"      Harrington WJ Jr, Sheremata WA, Snodgrass SR, et al. Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retroviruses 1991; 7:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/34\">",
"      Oh U, Yamano Y, Mora CA, et al. Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease. Ann Neurol 2005; 57:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/35\">",
"      Olindo S, Cabre P, L&eacute;zin A, et al. Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 2006; 63:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/36\">",
"      Leite AC, Mendon&ccedil;a GA, Serpa MJ, et al. Neurological manifestations in HTLV-I-infected blood donors. J Neurol Sci 2003; 214:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/37\">",
"      Silva MT, Harab RC, Leite AC, et al. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection. Clin Infect Dis 2007; 44:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/38\">",
"      Biswas HH, Engstrom JW, Kaidarova Z, et al. Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy. Neurology 2009; 73:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/39\">",
"      Sweet RD. A pattern of eczema in Jamaica. Br J Dermatol 1966; 78:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/40\">",
"      LaGrenade L, Hanchard B, Fletcher V, et al. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990; 336:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/41\">",
"      La Grenade L, Manns A, Fletcher V, et al. Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children. Arch Dermatol 1998; 134:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/42\">",
"      de Oliveira Mde F, Fatal PL, Primo JR, et al. Infective dermatitis associated with human T-cell lymphotropic virus type 1: evaluation of 42 cases observed in Bahia, Brazil. Clin Infect Dis 2012; 54:1714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/43\">",
"      Ohba N, Matsumoto M, Sameshima M, et al. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol 1989; 33:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/44\">",
"      Mochizuki M, Tajima K, Watanabe T, Yamaguchi K. Human T lymphotropic virus type 1 uveitis. Br J Ophthalmol 1994; 78:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/45\">",
"      Nishioka K, Maruyama I, Sato K, et al. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989; 1:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/46\">",
"      Nakamura H, Eguchi K, Nakamura T, et al. High prevalence of Sj&ouml;gren's syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 1997; 56:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/47\">",
"      Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989; 2:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/48\">",
"      Sugimoto M, Nakashima H, Watanabe S, et al. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987; 2:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/49\">",
"      Ono K, Shimamoto Y, Matsuzaki M, et al. Diffuse panbronchiolitis as a pulmonary complication in patients with adult T-cell leukemia. Am J Hematol 1989; 30:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/50\">",
"      Kadota J, Mukae H, Fujii T, et al. Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest 2004; 125:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/51\">",
"      Fujii M, Sumi Y, Atarashi K, et al. Muscle weakness in extremities and diffuse centrilobular nodules in lungs. HTLV-1-associated bronchiolo-alveolar disorder. Thorax 2011; 66:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/52\">",
"      Okada F, Ando Y, Yoshitake S, et al. Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology 2006; 240:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/53\">",
"      Yamashiro T, Kamiya H, Miyara T, et al. CT scans of the chest in carriers of human T-cell lymphotropic virus type 1: presence of interstitial pneumonia. Acad Radiol 2012; 19:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/54\">",
"      Einsiedel L, Fernandes L, Spelman T, et al. Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population. Clin Infect Dis 2012; 54:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/55\">",
"      Matsushita K, Ozaki A, Arima N, Tei C. Human T-lymphotropic virus type I infection and idiopathic thrombocytopnic purpura. Hematology 2005; 10:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/56\">",
"      Matsumoto S, Yamasaki K, Tsuji K, Shirahama S. Human T lymphotropic virus type 1 infection and gastric cancer development in Japan. J Infect Dis 2008; 198:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/57\">",
"      Isomoto H, Mizuta Y, Fukushima K, et al. Low prevalence of Helicobacter pylori in individuals with HTLV-I infection. Eur J Gastroenterol Hepatol 1999; 11:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/58\">",
"      Kline RL, Brothers T, Halsey N, et al. Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II. Lancet 1991; 337:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/59\">",
"      Ikeda M, Fujino R, Matsui T, et al. A new agglutination test for serum antibodies to adult T-cell leukemia virus. Gann 1984; 75:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/60\">",
"      Wiktor SZ, Alexander SS, Shaw GM, et al. Distinguishing between HTLV-I and HTLV-II by western blot. Lancet 1990; 335:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/61\">",
"      Yao K, Hisada M, Maloney E, et al. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I. J Infect Dis 2006; 193:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/62\">",
"      Miley WJ, Suryanarayana K, Manns A, et al. Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res Hum Retroviruses 2000; 16:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/63\">",
"      Duggan DB, Ehrlich GD, Davey FP, et al. HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA. Blood 1988; 71:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/64\">",
"      Macchi B, Balestrieri E, Mastino A. Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro. J Antimicrob Chemother 2003; 51:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/65\">",
"      Bazarbachi A, Hermine O. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13 Suppl 1:S186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/66\">",
"      Balestrieri E, Forte G, Matteucci C, et al. Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro. Antimicrob Agents Chemother 2002; 46:3080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/67\">",
"      Garc&iacute;a-Lerma JG, Nidtha S, Heneine W. Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine. J Infect Dis 2001; 184:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/68\">",
"      Machuca A, Rod&eacute;s B, Soriano V. The effect of antiretroviral therapy on HTLV infection. Virus Res 2001; 78:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/69\">",
"      Taylor GP, Goon P, Furukawa Y, et al. Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial. Retrovirology 2006; 3:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/70\">",
"      Taylor GP, Hall SE, Navarrete S, et al. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J Virol 1999; 73:10289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40808/abstract/71\">",
"      Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group. Ann Intern Med 1993; 118:448.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8317 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-CCFD8525CC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40808=[""].join("\n");
var outline_f39_54_40808=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DISEASE ASSOCIATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Adult T cell leukemia-lymphoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Acute",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Lymphomatous",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Chronic",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Smoldering",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Markers of disease progression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HTLV-I-associated myelopathy/tropical spastic paraparesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Prognosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other disease manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other neurological abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Infective dermatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Uveitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Rheumatologic and pulmonary disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Immune thrombocytopenia (ITP)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      TREATMENT AND PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8317\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8317|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/40/4736\" title=\"picture 1\">",
"      Adult T cell Leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8317|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/48/7947\" title=\"table 1\">",
"      Diseases associated with HTLV-1 infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/29/38364\" title=\"table 2\">",
"      WHO diagnostic criteria for HTLV I associated myelopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9945?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of adult T cell leukemia-lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/48/5897?source=related_link\">",
"      Human T-lymphotropic virus type I: Virology, pathogenesis, and epidemiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/36/30281?source=related_link\">",
"      Treatment and prognosis of adult T cell leukemia-lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_54_40809="Laboratory tests to support the clinical diagnosis of anaphylaxis";
var content_f39_54_40809=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Laboratory tests to support the clinical diagnosis of anaphylaxis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40809/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40809/contributors\">",
"     Lawrence B Schwartz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40809/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40809/contributors\">",
"     F Estelle R Simons, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/54/40809/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/54/40809/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/54/40809/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaphylaxis is a serious systemic allergic reaction that is rapid in onset and may cause death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/1\">",
"     1",
"    </a>",
"    ]. The diagnosis of anaphylaxis during the acute event is based on the clinical presentation and a history of a recent exposure to an offending agent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/1\">",
"     1",
"    </a>",
"    ]. Currently, there are no laboratory tests available in an emergency department or clinic setting to confirm a diagnosis of anaphylaxis in real time. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serum, plasma, and possibly urine obtained during or shortly after the acute event, can, however, help to support the clinical diagnosis of anaphylaxis. These tests can also help identify anaphylaxis in the presence of other disorders that have overlapping clinical presentations, such as severe asthma or myocardial infarction. In addition, these tests may provide evidence for anaphylaxis as a cause of death.",
"   </p>",
"   <p>",
"    This topic reviews the laboratory tests that can be used to support the clinical diagnosis of anaphylaxis in both adults and children. These tests are different from those that identify sensitization to the inciting allergen, namely measurements of allergen-specific immunoglobulin E (IgE), which are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32633?source=see_link\">",
"     \"Overview of skin testing for allergic disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/22/44391?source=see_link\">",
"     \"Overview of in vitro allergy tests\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/11/9401?source=see_link&amp;anchor=H4433858#H4433858\">",
"     \"Anaphylaxis: Confirming the diagnosis and determining the trigger(s)\", section on 'Testing for allergen trigger(s)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principal effector cells of systemic anaphylaxis are mast cells and basophils. The various preformed and newly-generated mediators secreted by these cells cause many of the signs and symptoms of systemic anaphylaxis. The pathophysiology of anaphylaxis is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/21/18778?source=see_link\">",
"     \"Pathophysiology of anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Two of the most abundant and best-characterized preformed granule mediators released by these cells during anaphylaxis are tryptase and histamine. Elevations in tryptase and histamine can sometimes be detected in blood samples obtained shortly after the onset of symptoms. Also, elevated levels of histamine, histamine metabolites (N-methylhistamine and N-methylimidazole",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    ) and the prostaglandin (PG) D",
"    <sub>",
"     2",
"    </sub>",
"    metabolite, 11-beta-PGF2-alpha (11&beta;-PGF",
"    <sub>",
"     2&alpha;",
"    </sub>",
"    ), can be measured in urine after an anaphylactic event.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2357974\">",
"    <span class=\"h2\">",
"     Available tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assays for the following mediators are currently available commercially in the United States (",
"    <a class=\"graphic graphic_table graphicRef69698 \" href=\"mobipreview.htm?16/28/16844\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tryptase",
"      <span class=\"nowrap\">",
"       (serum/plasma)",
"      </span>",
"     </li>",
"     <li>",
"      Histamine (plasma)",
"     </li>",
"     <li>",
"      The histamine metabolites N-methylhistamine (urine)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    N-methylimidazole",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    (urine) and the prostaglandin D2 metabolite 11&beta;-PGF",
"    <sub>",
"     2&alpha;",
"    </sub>",
"    (urine) are intermittently available in some commercial laboratories.",
"   </p>",
"   <p>",
"    Chymase and mast cell carboxypeptidase A3 are also being investigated as markers of anaphylaxis, although these mediators require further study as biomarkers and assays for them are not widely available for routine clinical use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Possible future tests'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Time course of mediator release",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevations in tryptase and histamine may be transiently detectable following anaphylaxis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Total tryptase should be measured within 15 minutes to 3 hours after onset of anaphylaxis symptoms. Ideally, this level should be compared to one obtained at baseline, which could either be prior to the event or at least 24 hours after all signs and symptoms have resolved. During experimental insect-sting anaphylaxis, serum tryptase levels peak 15 to 60 minutes after the onset of symptoms and then decline with a half-life of about two hours [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]. Very large initial elevations of tryptase may remain detectable for several hours after the event. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Tryptase'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Histamine elevations are even more fleeting. Plasma histamine levels peak within 5 to 10 minutes after symptom onset, and decline with a half-life of one to two minutes such that levels typically return to baseline by 15 to 30 minutes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/3,5-7\">",
"       3,5-7",
"      </a>",
"      ]. Therefore, samples should be drawn as soon as possible, preferably within 30 minutes from the onset of symptoms. Metabolites of histamine are slightly longer lasting in blood, and may remain detectable in the urine for hours. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Histamine'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TRYPTASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tryptase is produced by both mast cells and basophils, although mast cells contain ~500-fold more than basophils [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. Upon activation, mast cells degranulate, releasing tryptase, along with histamine, into the extracellular environment. Because tryptase is relatively specific for mast cells, elevated tryptase levels in serum or plasma indicate involvement of these cells in clinical events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/11\">",
"     11",
"    </a>",
"    ]. The biologic functions of tryptase have not been fully defined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Forms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tryptase exists in mature and immature forms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The immature form, also known as protryptase, is spontaneously secreted by unstimulated mast cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/12\">",
"       12",
"      </a>",
"      ]. Specifically, &alpha;-protryptase and &beta;-protryptase account for the vast majority of the tryptase detected in nonanaphylactic serum. The function(s) of immature tryptases, other than serving as precursors of mature enzymes, are not known [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/13\">",
"       13",
"      </a>",
"      ]. Protryptases can be proteolytically processed to maturity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mature &beta;-tryptase, and possibly mature &alpha;-tryptase, is stored inside the secretory granules of mast cells as an enzymatically active tetramer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/15\">",
"       15",
"      </a>",
"      ] in a complex with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      proteoglycan [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/16,17\">",
"       16,17",
"      </a>",
"      ]. When mast cells become activated and degranulate, mature tryptase and histamine are released into the extracellular environment. In vitro potential biologic activities of mature &beta;-tryptase include generation of complement anaphylatoxins, inactivation of fibrinogen, and stimulation of a variety of different cell types, while its activity(ies) in vivo remain uncertain. Unlike &beta;-tryptase, &alpha;-tryptase is nearly inactive as a protease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genes for the main human tryptases reside on chromosome 16. The dimorphic TPSAB1 gene can give rise to alpha- or beta-tryptase, and the monomorphic TPSB2 gene gives rise to beta-tryptase only. Humans have four functional tryptase genes (two from each parent). About 25 percent of people have two alpha and two beta genes, approximately 50 percent have one alpha and three beta genes, and the remaining 25 percent have four beta genes.",
"   </p>",
"   <p>",
"    Genotype has a small effect on the level of total tryptase. Specifically, healthy individuals with four beta genes have the lowest total tryptase levels. Those with three beta and one alpha have levels ~0.5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    higher, and those with two alpha and two beta genes, ~0.5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    higher still. Total tryptase values from individuals with all genotypes are incorporated into the normal range. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Normal levels'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two immunoassays for tryptase have been developed and applied clinically:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An assay for all forms of alpha- and beta-tryptases, in combination, or \"total\" tryptase, is commercially available as \"ImmunoCAP tryptase\" (Thermo Fisher Scientific Inc. (previously Phadia: Uppsala, Sweden)), through many commercial labs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An immunoassay for mature tryptase is presently performed only at the author's laboratory at Virginia Commonwealth University (Richmond, Virginia) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/19\">",
"       19",
"      </a>",
"      ]. In addition to mature tryptase, this lab also routinely measures total tryptase by ImmunoCAP&reg; on each sample provided, and monitors for the presence of heterophilic antibody (See",
"      <a class=\"local\" href=\"#H1046138\">",
"       'Causes of false positive elevations'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Proper collection of samples",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum or plasma for tryptase should be obtained ideally within the first one to three hours after anaphylaxis (",
"    <a class=\"graphic graphic_table graphicRef69698 \" href=\"mobipreview.htm?16/28/16844\">",
"     table 1",
"    </a>",
"    ). An additional sample should be collected at least 24 hours after all signs and symptoms have resolved, to serve as a baseline sample. Frozen serum or plasma obtained before the event can also be used as a baseline, and is often available for hospitalized patients. Tryptase is stable in frozen serum for at least one year.",
"   </p>",
"   <p>",
"    The author's lab requires 1 mL of serum (red top tube) or plasma (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , citrate or EDTA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/19\">",
"     19",
"    </a>",
"    ]. The sample should optimally be stored and shipped frozen by overnight courier, although the enzyme appears to be immunologically stable, if refrigerated, for more than one week. Samples left at room temperature for more than one or two days might yield falsely low values. Printable instructions for proper collection and handling are provided (",
"    <a class=\"graphic graphic_table graphicRef72041 \" href=\"mobipreview.htm?21/8/21644\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For postmortem samples, collection from the femoral artery or vein, rather than the heart, is recommended to minimize the contribution of nonspecifically released tryptase from mast cells in disintegrating or traumatized cardiac tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Normal levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Baseline serum levels of mature tryptase are normally undetectable (&lt;1",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    in healthy individuals who have not experienced anaphylaxis in the preceding few hours. Baseline total tryptase levels range from 1 to 11.4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    with an average of 3 to 5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef79722 \" href=\"mobipreview.htm?37/24/38283\">",
"     table 3",
"    </a>",
"    ). The upper limit of 11.4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    is recommended by the manufacturer. Healthy females have a total tryptase level about 0.2",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    higher than healthy males.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Elevations in anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated levels of mature or total tryptase in the serum may be useful for distinguishing anaphylaxis from other conditions in the differential diagnosis, such as vasovagal reactions, septic shock, seizures, myocardial shock, benign flushing, or carcinoid syndrome. These other disorders are NOT normally associated with elevations in serum mature or total tryptase levels. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/62/38888?source=see_link\">",
"     \"Differential diagnosis of anaphylaxis in children and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An increased level of mature tryptase in serum indicates that mast cell (and possibly basophil) activation has occurred. There is no other known condition that results in selective elevations of mature tryptase. Total tryptase levels may also rise during anaphylaxis, and a rise in total tryptase levels above baseline may be at least as sensitive as a single mature tryptase level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/21\">",
"     21",
"    </a>",
"    ]. The minimal elevation of the acute total tryptase level that is considered to be clinically significant was suggested to be 2 + 1.2 x baseline tryptase levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/22\">",
"     22",
"    </a>",
"    ]. The ratio of total to mature tryptase during systemic anaphylaxis is typically &lt;10, and approaches unity at higher levels of mature tryptase (",
"    <a class=\"graphic graphic_table graphicRef79722 \" href=\"mobipreview.htm?37/24/38283\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Elevations during anaphylaxis can range from marginally elevated, to levels &gt;100",
"    <span class=\"nowrap\">",
"     ng/mL.",
"    </span>",
"    Dramatic elevations have been recorded following anaphylactic shock induced by medications, for example.",
"   </p>",
"   <p>",
"    Both total and mature tryptase levels should be higher in the acute than in the baseline sample. Comparing acute and baseline levels greatly improves the diagnostic value of total tryptase measurements. If total tryptase is the only test available, then paired levels are essential for interpretation (",
"    <a class=\"graphic graphic_figure graphicRef58418 \" href=\"mobipreview.htm?42/13/43231\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Higher baseline levels of total tryptase increase the risk for more severe anaphylaxis, particularly in insect venom-sensitive subjects, to both field stings and to venom immunotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Also, patients with a history of systemic anaphylaxis to insect stings and a baseline tryptase level &gt;11.4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    have a high prevalence of underlying clonal mast cell disease (systemic mastocytosis or mast cell activation syndrome) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/13/18650?source=see_link&amp;anchor=H30#H30\">",
"     \"Evaluation and diagnosis of mastocytosis (cutaneous and systemic)\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1045841\">",
"    <span class=\"h3\">",
"     Relationship to hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;During insect sting-induced anaphylaxis, the magnitude of the serum tryptase elevation correlates closely with the drop in mean arterial pressure, indicating that the magnitude of mast cell activation is a primary determinant of clinical severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/5,21\">",
"     5,21",
"    </a>",
"    ]. In the absence of hypotension, it is unlikely that enough tryptase will be released from mast cells to raise systemic levels of mature tryptase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1045864\">",
"    <span class=\"h3\">",
"     Food-induced anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated levels of total tryptase during acute clinical events implicate mast cell involvement. However, total tryptase levels are seldom elevated in clinically obvious food-induced anaphylaxis, even if blood samples were obtained in a timely manner, or following clinician-supervised, positive food challenge tests, when the precise times between food ingestion, onset of signs and symptoms of anaphylaxis, and collection of the blood sample were recorded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Several possible explanations have been proposed, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Localized rather than systemic release of mast cell mediators may occur in some victims of anaphylaxis, eg, those with laryngeal edema.",
"     </li>",
"     <li>",
"      Tryptase released by mast cells at mucosal sites may not diffuse into the circulation as efficiently as that released near blood vessels, and mast cells at mucosal surfaces contain less tryptase than those in the skin and perivascular tissues.",
"     </li>",
"     <li>",
"      There may be IgE-dependent anaphylactic pathways that bypass mast cells and involve basophils",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      other cell types. Proving basophil-dependent anaphylaxis has been problematic because there is no test at present for specifically detecting basophil activation.",
"     </li>",
"     <li>",
"      Other pathways that could clinically mimic anaphylaxis might include production of vasoactive mediators, such as complement anaphylatoxins (C3a and C5a), kinins, or lipids. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/21/18778?source=see_link\">",
"       \"Pathophysiology of anaphylaxis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Fatal anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postmortem tryptase levels have been studied in cases of fatal anaphylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. In one series, mature tryptase was significantly elevated (12 to 150",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    in 9 of 9 hymenoptera sting fatalities, 6 of 8 food-induced fatalities, and 2 of 2 reactions to diagnostic therapeutic agents, whereas levels were normal in six postmortem controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/27\">",
"     27",
"    </a>",
"    ]. A level of &gt;10",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    for mature tryptase (normal &lt;1",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    was thought to indicate a magnitude of mast cell activation consistent with anaphylactic shock near the time of death. A study of total tryptase levels in postmortem sera suggests that a total tryptase level &gt;45",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    is consistent with systemic anaphylaxis having occurred near the time of death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/29\">",
"     29",
"    </a>",
"    ]. The etiology and pathogenesis of fatal anaphylaxis are reviewed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/13/1241?source=see_link\">",
"     \"Fatal anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h4\">",
"     Diagnostic specificity of postmortem levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic specificity of postmortem tryptase levels has been challenged by a study that found elevated levels of mature tryptase in approximately 10 percent (5 of 49) of fatalities believed to be nonanaphylactic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/30\">",
"     30",
"    </a>",
"    ]. In the five patients with postmortem tryptase levels &gt;10",
"    <span class=\"nowrap\">",
"     ng/mL:",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One",
"      death was attributed to salicylate overdose, although",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      sensitivity could have coexisted and caused mast cell activation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/30\">",
"       30",
"      </a>",
"      ]. Mast cell activation has been well-documented in aspirin-sensitive subjects challenged with aspirin-like drugs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/31-34\">",
"       31-34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another death was associated with atherosclerotic coronary vascular disease, although details were not available regarding drugs received near the time of death that could have activated mast cells, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      The remaining three individuals died of trauma, and although there are few studies on serum tryptase elevations in trauma patients, elevated tryptase levels in peritoneal lavage fluids have been noted in patients following intestinal manipulation during abdominal surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In other postmortem studies, elevated levels of mature tryptase were reported in the sudden infant death syndrome, heroin-related deaths, and unexplained deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/20,36,37\">",
"     20,36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Conclusions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Collection of blood for tryptase measurements should be considered if the diagnosis of anaphylaxis is being entertained. Elevations in tryptase correlate with hypotension and support the diagnosis of anaphylaxis, although normal levels do not exclude anaphylaxis, particularly in food-induced reactions. The specificity and sensitivity of tryptase elevations have not been determined.",
"   </p>",
"   <p>",
"    Samples should be ideally collected within one to three hours of the event, or as soon as possible thereafter. Large elevations in tryptase may persist for several hours.",
"   </p>",
"   <p>",
"    Mature tryptase is more specific for mast cell activation than total tryptase, although the predictive value of both measurements (particularly that of total tryptase) is improved by comparison with a baseline sample.",
"   </p>",
"   <p>",
"    Detailed descriptions of the clinical event and medications received before and during the event are needed for optimal interpretation of tryptase levels. The manner in which blood was obtained can sometimes affect postmortem specimens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Elevations of tryptase in nonanaphylactic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The levels of total tryptase in nonanaphylactic subjects is largely composed of immature protryptases and reflect, in part, the total body burden of mast cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Systemic mastocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Total tryptase is markedly elevated (&gt;20",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    in most patients with systemic mastocytosis, a disorder of clonal mast cell hyperplasia. The",
"    <span class=\"nowrap\">",
"     total/mature",
"    </span>",
"    ratio is usually &gt;20 (",
"    <a class=\"graphic graphic_table graphicRef79722 \" href=\"mobipreview.htm?37/24/38283\">",
"     table 3",
"    </a>",
"    ). A total tryptase level &gt;20",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    is just one of the four WHO minor criteria for diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/38\">",
"     38",
"    </a>",
"    ]. A baseline serum total tryptase level has been approved by the US Food and Drug Administration (FDA) for use in the evaluation of suspected systemic mastocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/39\">",
"     39",
"    </a>",
"    ]. Systemic mastocytosis may present with spontaneous, insect sting-induced, or allergen-induced anaphylaxis. The diagnosis of systemic mastocytosis is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/13/18650?source=see_link\">",
"     \"Evaluation and diagnosis of mastocytosis (cutaneous and systemic)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated total tryptase levels are also observed in acute myelocytic leukemia, myelodysplastic syndromes, and the myeloid variants of hypereosinophilic syndrome (particularly those associated with the FIP1L1-PDGFRA mutation) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. Elevated total tryptase can also be seen with treatment of onchocerciasis, after administration of recombinant stem cell factor, in anuric patients with end-stage renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/43,44\">",
"     43,44",
"    </a>",
"    ], or rarely as a normal variant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/45-47\">",
"     45-47",
"    </a>",
"    ]. In these conditions, the mature tryptase level in the serum is normal or minimally elevated such that the ratio of total to mature tryptase exceeds 20, similar to the pattern seen with systemic mastocytosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1046138\">",
"    <span class=\"h3\">",
"     Causes of false positive elevations",
"    </span>",
"    &nbsp;&mdash;&nbsp;False elevations in tryptase levels have been associated with the presence of heterophilic antibodies in a patient's serum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/48-50\">",
"     48-50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who have received any mouse-human chimeric antibody, such as the chimeric (mouse",
"    <span class=\"nowrap\">",
"     Fab/human",
"    </span>",
"    Fc) antibody",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    , or individuals who have extensive exposure to mice are at increased risk for having such heterophilic antibodies. The prevalence of false elevations in tryptase is higher in subjects that are rheumatoid factor positive, although the IgG or IgM rheumatoid factors recognizing human IgG may not be the culprits binding to the mouse antitryptase antibodies used in the immunoassay. Instead, these individuals are more likely to have human anti-mouse antibodies that crosslink the capture and detector mouse antitryptase antibodies, similar to how tryptase crosslinks these antibodies.",
"   </p>",
"   <p>",
"    Phadia began adding a heterophilic antibody suppressor to their tryptase kit in early 2011, which should reduce such false positives. Such a reagent has been added to tryptase measurements performed by the author since 2005. In addition, the author's diagnostic lab at Virginia Commonwealth University performs a negative control ELISA using a mouse nonimmune detector antibody that appears positive in the presence of heterophilic antibody, but not in the presence of tryptase, which serves as a warning of the presence of breakthrough heterophilic antibody activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     HISTAMINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histamine is a biogenic amine produced by and stored in human mast cells and basophils, and is the only preformed granule mediator of these cells known to have direct potent vasoactive and smooth muscle spasmogenic activities. Mast cells and basophils produce comparable amounts of histamine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histamine is generated intracellularly from histidine by histidine decarboxylase. Most of this histamine is then stored in the secretory granules of mast cells and basophils, although a small portion is released constitutively. Histamine binds to carboxyl and possibly sulfate moieties on proteins and proteoglycans in the acidic pH environment of secretory granules. However, in the neutral pH of the extracellular environment, histamine is less positively charged and becomes dissociated from the macromolecular structures to which it had been bound. Free histamine has low molecular mass (111 Da) and high solubility, and rapidly diffuses away from its local sites of release. A portion may enter the circulation. A smaller amount of free histamine may pass into the urine unmetabolized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Elevations during anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to tryptase, any elevation in plasma or urine histamine is consistent with anaphylaxis, although normal levels do not exclude the diagnosis.",
"   </p>",
"   <p>",
"    Histamine elevations correlate well with clinical severity of anaphylaxis. Although histamine levels in properly collected samples of plasma have a greater sensitivity than tryptase, the short plasma half-life of histamine and the difficulties in handling the sample usually limit the utility of this measurement in the clinical setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Histamine metabolites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within minutes, the majority of released histamine is sequentially metabolized to N-methylhistamine and then to N-methylimidazole",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    by histamine N-methyl transferase and monoamine oxidase, or to imidazole acetic acid by diamine oxidase. N-methylhistamine and N-methylimidazole acetic acid are specific metabolites of histamine, while imidazole acetic acid is not. Levels of N-methylhistamine or N-methylimidazole acetic acid, which can be measured in plasma or urine, may also reflect overall levels of released histamine. These metabolites may be detectable in the urine for several hours after anaphylaxis. Elevated urinary N-methylhistamine was observed in specimens collected six hours after an insect sting challenge in patients experiencing systemic anaphylactic symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some investigators consider these metabolites to be more reliable indicators of histamine release than histamine itself. N-methylhistamine is longer-lived than histamine in the circulation, accounts for a greater portion of the released histamine that ends up in the urine, and demonstrates less natural diurnal variation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. However, another study of anaphylaxis during anesthesia found urinary N-methylhistamine to be less sensitive than either plasma tryptase or histamine, so the relative merits of histamine and its metabolites are not fully defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In summary, urinary histamine, N-methylhistamine or methylimidazole",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    levels are helpful when elevated above baseline, but normal levels do not exclude mast cell activation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Assays and collection of samples",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assays are commercially available to measure histamine and its metabolites in biologic fluids (",
"    <a class=\"graphic graphic_table graphicRef69698 \" href=\"mobipreview.htm?16/28/16844\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Blood",
"      </strong>",
"      &mdash; Normal levels of histamine in plasma are ~2 nM. Plasma should be used, rather than serum, to avoid the artifactual release of histamine from basophils that can occur during clotting. The blood sample must be collected through a 20-gauge or larger needle, and pulled manually under gentle pressure into a syringe containing either citrate or EDTA; pulling blood through a narrow-bore needle under vacuum can also cause basophil activation or breakage ex vivo and falsely elevate the levels of histamine. Collected anticoagulated blood should be placed on ice and centrifuged to separate plasma from cells as soon as possible, and then frozen until ready to be analyzed. Printable instructions for collection and handling are provided (",
"      <a class=\"graphic graphic_table graphicRef72041 \" href=\"mobipreview.htm?21/8/21644\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Urine",
"      </strong>",
"      &mdash; Urine for measuring levels of histamine are collected with a standard 24-hour collection. Collection should begin as soon as possible after the acute event. A urinary histamine concentration of up to 30",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      is considered normal. Ideally, a second baseline sample should be collected beginning at least 24 hours after all signs and symptoms of anaphylaxis have ceased. Instructions for collecting, storing, and shipping urine specimens can be found at",
"      <a class=\"external\" href=\"file://www.mayomedicallaboratories.com/\">",
"       file://www.mayomedicallaboratories.com",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Other causes of elevated histamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevations in plasma or urinary histamine may result from the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Urinary histamine and its metabolites may be elevated due to the presence of histamine-producing bacteria in the urogenital or gastrointestinal tracts, although this has not been extensively studied [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Histamine-rich foods include some fish, aged cheeses, chocolate, red wine, and vegetables, such as eggplant, spinach, and tomatoes, although the relationship between the histamine content in foods and the appearance of that histamine or its metabolites in the circulation or urine is uncertain, in part because the factors affecting absorption of ingested histamine are unclear [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/58,59\">",
"       58,59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Scombroidosis, an illness that results from the ingestion of improperly-stored fish that has accumulated high histamine levels, presents with flushing, headache, and widened pulse pressure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/60\">",
"       60",
"      </a>",
"      ], but not with pruritic urticaria and hypotension as seen in systemic anaphylaxis. Often several people eating the same fish are affected. Urinary and plasma histamine or histamine metabolite levels can be elevated, although tryptase levels are normal. Elevated histamine levels are not found in other forms of food poisoning. The diagnosis of Scombroidosis is reviewed in more detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/61/16346?source=see_link&amp;anchor=H20#H20\">",
"       \"Seafood allergies: Fish and shellfish\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Constitutive hyperhistaminemia may be a contributing mechanism in recurrent anaphylaxis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Levels of histamine may be elevated in adults with systemic mastocytosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/13/18650?source=see_link\">",
"       \"Evaluation and diagnosis of mastocytosis (cutaneous and systemic)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5038436\">",
"    <span class=\"h1\">",
"     PROSTAGLANDIN AND METABOLITES",
"    </span>",
"    &nbsp;&mdash;&nbsp;PGD",
"    <sub>",
"     2",
"    </sub>",
"    is the principal cyclooxygenase produced by activated mast cells, but not by basophils. Antigen presenting cells, megakaryocytes, and TH2 lymphocytes are also capable of producing this prostaglandin. PGD",
"    <sub>",
"     2",
"    </sub>",
"    plays a large role in the hemodynamic changes that accompany episodes of systemic mast cell activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/62\">",
"     62",
"    </a>",
"    ]. Like histamine, clearance from the systemic circulation is rapid, and elevated serum levels of PGD",
"    <sub>",
"     2",
"    </sub>",
"    are generally difficult to detect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/4\">",
"     4",
"    </a>",
"    ]. Elevations of the major circulating and excreted metabolite (11&beta;-PGF",
"    <sub>",
"     2&alpha;",
"    </sub>",
"    ) can be measured in the urine, where it may be a more sensitive indicator of mast cell activation than N-methylhistamine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/63-65\">",
"     63-65",
"    </a>",
"    ]. Urinary prostaglandin is available through a limited number of commercial labs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Measurement of PGD",
"    <sub>",
"     2",
"    </sub>",
"    is",
"    <strong>",
"     not",
"    </strong>",
"    useful in patients receiving cyclooxygenase inhibitors, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and other nonsteroidal antiinflammatory drugs (NSAIDs), as these medications block the synthesis of this mediator. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/19/1336?source=see_link\">",
"     \"NSAIDs: Mechanism of action\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     POSSIBLE FUTURE TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chymase, mast cell carboxypeptidase A3, and leukotriene (LT)E",
"    <sub>",
"     4",
"    </sub>",
"    are other products that have been evaluated as possible markers of anaphylaxis. Assays for these mediators are not widely available commercially, although they are performed in research labs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Chymase and carboxypeptidase A3",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chymase and carboxypeptidase A3 are mast-cell derived proteases that are expressed by a subset of mast cells called MC",
"    <sub>",
"     TC",
"    </sub>",
"    cells, which are the predominant type of mast cells in skin, perivascular tissue, heart, conjunctiva, and bowel submucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/67\">",
"     67",
"    </a>",
"    ]. Chymase and carboxypeptidase A3 are stored in secretory granules and are released from mast cells as a macromolecular protease:proteoglycan complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/15\">",
"     15",
"    </a>",
"    ]. Subtypes of mast cells are reviewed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/22/44393?source=see_link\">",
"     \"Mast cells: Development, identification, and physiologic roles\"",
"    </a>",
"    .) These proteases are not expressed by basophils.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chymase levels measured by ELISA in postmortem serum were elevated (&gt;3",
"      <span class=\"nowrap\">",
"       ng/mL)",
"      </span>",
"      in fatal anaphylaxis, correlated with elevated levels of tryptase, and were undetectable in most cases of nonanaphylactic deaths [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/68\">",
"       68",
"      </a>",
"      ]. Further evaluation of this marker of anaphylaxis is needed.",
"     </li>",
"     <li>",
"      Carboxypeptidase A3 levels measured by an ELISA were elevated (&gt;14",
"      <span class=\"nowrap\">",
"       ng/mL)",
"      </span>",
"      in serum obtained from individuals with a clinical diagnosis of anaphylaxis, but not in healthy controls or those with asthma or atopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/69,70\">",
"       69,70",
"      </a>",
"      ]. However, carboxypeptidase A3 and total tryptase levels did not correlate with one another, perhaps because of delayed diffusion of carboxypeptidase A3 into the circulation. Further studies of this potential biomarker are needed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5038668\">",
"    <span class=\"h2\">",
"     Sulfidopeptide leukotrienes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leukotriene (LT)C",
"    <sub>",
"     4",
"    </sub>",
"    is newly-generated and secreted by activated mast cells, as well as other cell types such as eosinophils and basophils. Once secreted it is sequentially metabolized to LTD",
"    <sub>",
"     4",
"    </sub>",
"    and LTE",
"    <sub>",
"     4",
"    </sub>",
"    . LTE",
"    <sub>",
"     4",
"    </sub>",
"    levels in the urine are elevated in patients with systemic mastocytosis patients and with systemic anaphylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/54/40809/abstract/71\">",
"     71",
"    </a>",
"    ]. However, assays for this metabolite are not readily available except in research laboratories, and more research is needed to determine their clinical utility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     TESTS FOR CONDITIONS MIMICKING ANAPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaphylaxis can be difficult to distinguish from other medical conditions that mimic signs or symptoms of anaphylaxis, particularly in the absence of an inciting allergen. For example, flushing occurs with the carcinoid syndrome, VIPomas, and pheochromocytomas. To help distinguish these entities from anaphylaxis, several laboratory tests should be considered, when clinically appropriate (",
"    <a class=\"graphic graphic_table graphicRef61358 \" href=\"mobipreview.htm?7/55/8059\">",
"     table 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plasma-free metanephrine and urinary vanillylmandelic acid are elevated in pheochromocytoma (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/14/23786?source=see_link\">",
"       \"Clinical presentation and diagnosis of pheochromocytoma\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Serum serotonin and urinary-5-hydroxyindoleacetic acid may be elevated in the carcinoid syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/8/11400?source=see_link\">",
"       \"Diagnosis of the carcinoid syndrome and tumor localization\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Pancreastatin, vasoactive intestinal peptide, substance P, neurokinin,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      calcitonin may be elevated in gastrointestinal VIPomas or medullary carcinoma of the thyroid (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/59/16311?source=see_link\">",
"       \"The VIPoma syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link\">",
"       \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The differential diagnosis of anaphylaxis is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/62/38888?source=see_link\">",
"     \"Differential diagnosis of anaphylaxis in children and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/57/15250?source=see_link\">",
"       \"Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/14/41186?source=see_link\">",
"       \"Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of anaphylaxis is made clinically, and there are currently no laboratory tests available in an emergency department or clinic setting to verify a diagnosis of anaphylaxis in real time. However, serum, plasma, and urine obtained during or shortly after the acute event, can support the clinical diagnosis of anaphylaxis. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mast cells and basophils are the principal effector cells of systemic anaphylaxis and release a variety of mediators upon activation. Assays for tryptase (serum or plasma), histamine (plasma), and histamine metabolites (urine) are available commercially (",
"      <a class=\"graphic graphic_table graphicRef69698 \" href=\"mobipreview.htm?16/28/16844\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tryptase should be measured within 15 minutes to 3 hours after onset of anaphylaxis symptoms (",
"      <a class=\"graphic graphic_table graphicRef72041 \" href=\"mobipreview.htm?21/8/21644\">",
"       table 2",
"      </a>",
"      ). Plasma histamine levels should be measured preferably less than 30 minutes after symptom onset. Urinary metabolites of histamine may remain elevated for several hours after an anaphylactic event. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Time course of mediator release'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tryptase exists in mature and immature (precursor) forms. The immature forms are constitutively released and reflect total body mast cell content, while mature tryptase is released from mast cells upon degranulation (ie, in anaphylaxis). Assays for total tryptase, which are available commercially, measure both immature and mature forms of tryptase. The only assay currently available for mature tryptase is performed in the author's laboratory (",
"      <a class=\"graphic graphic_table graphicRef69698 \" href=\"mobipreview.htm?16/28/16844\">",
"       table 1",
"      </a>",
"      ). Both mature and total tryptase can be useful in the evaluation of anaphylaxis, although levels of mature tryptase are more specific. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Tryptase'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Any elevation in mature tryptase in serum or plasma is suggestive of anaphylaxis, although normal levels do not exclude the diagnosis. Total tryptase will rise after anaphylaxis, but a follow-up baseline sample is required to interpret total tryptase accurately (",
"      <a class=\"graphic graphic_figure graphicRef58418 \" href=\"mobipreview.htm?42/13/43231\">",
"       figure 1",
"      </a>",
"      ). The ratio of total to mature tryptase during systemic anaphylaxis is typically &lt;10. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Elevations in anaphylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conditions that cause elevated total tryptase, with minimal elevations in mature tryptase, include systemic mastocytosis, acute myelocytic leukemia, myelodysplastic syndromes, hypereosinophilic syndrome (myelocytic variant), and onchocerciasis (during active treatment). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Systemic mastocytosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Other conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plasma histamine elevations correlate well with clinical severity of anaphylaxis, although elevations are fleeting, and blood samples must be handled with great care, limiting the practical utility of this test (",
"      <a class=\"graphic graphic_table graphicRef72041 \" href=\"mobipreview.htm?21/8/21644\">",
"       table 2",
"      </a>",
"      ). Urinary metabolites of histamine are longer-lasting and can be assayed in a routine 24-hour urine sample. Like tryptase, any elevations of these mediators support the diagnosis of anaphylaxis, but normal levels do not exclude the possibility of anaphylaxis. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Histamine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chymase, mast cell carboxypeptidase A3, and leukotriene E",
"      <sub>",
"       4",
"      </sub>",
"      are other products that may be useful in the future for diagnosing anaphylaxis. These assays are currently available only in research settings. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Possible future tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several other laboratory tests are useful in excluding rare disorders that can mimic anaphylaxis (",
"      <a class=\"graphic graphic_table graphicRef61358 \" href=\"mobipreview.htm?7/55/8059\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Tests for conditions mimicking anaphylaxis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/1\">",
"      Sampson HA, Mu&ntilde;oz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/2\">",
"      Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008; 358:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/3\">",
"      Schwartz LB, Yunginger JW, Miller J, et al. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989; 83:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/4\">",
"      van der Linden PW, Hack CE, Poortman J, et al. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 1992; 90:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/5\">",
"      van der Linden PW, Struyvenberg A, Kraaijenhagen RJ, et al. Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction. Ann Intern Med 1993; 118:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/6\">",
"      Smith PL, Kagey-Sobotka A, Bleecker ER, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/7\">",
"      Halmerbauer G, Hauk P, Forster J, et al. In vivo histamine release during the first minutes after deliberate sting challenges correlates with the severity of allergic symptoms. Pediatr Allergy Immunol 1999; 10:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/8\">",
"      Castells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 1987; 138:2184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/9\">",
"      Jogie-Brahim S, Min HK, Fukuoka Y, et al. Expression of alpha-tryptase and beta-tryptase by human basophils. J Allergy Clin Immunol 2004; 113:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/10\">",
"      Schwartz LB, Irani AM, Roller K, et al. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol 1987; 138:2611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/11\">",
"      Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 2006; 26:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/12\">",
"      Schwartz LB, Min HK, Ren S, et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells. J Immunol 2003; 170:5667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/13\">",
"      Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 2007; 217:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/14\">",
"      Schwartz LB, Bradford TR. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem 1986; 261:7372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/15\">",
"      Goldstein SM, Leong J, Schwartz LB, Cooke D. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. J Immunol 1992; 148:2475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/16\">",
"      Le QT, Min HK, Xia HZ, et al. Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C. J Immunol 2011; 186:7136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/17\">",
"      Pereira PJ, Bergner A, Macedo-Ribeiro S, et al. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 1998; 392:306.",
"     </a>",
"    </li>",
"    <li>",
"     ImmunoCAP Tryptase, Phadia AB, Uppsala, Sweden. www.phadia.com (Accessed on May 24, 2010).",
"    </li>",
"    <li>",
"     The author's laboratory can provide additional information to clinicians regarding sample preparation, cost, shipping, and interpretation of results. The laboratory can be contacted at (804) 828-9685.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/20\">",
"      Edston E, van Hage-Hamsten M. beta-Tryptase measurements post-mortem in anaphylactic deaths and in controls. Forensic Sci Int 1998; 93:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/21\">",
"      Schwartz LB, Bradford TR, Rouse C, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 1994; 14:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/22\">",
"      Valent P, Akin C, Arock M, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 2012; 157:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/23\">",
"      Ru&euml;ff F, Przybilla B, Bil&oacute; MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/24\">",
"      Ru&euml;ff F, Przybilla B, Bil&oacute; MB, et al. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol 2010; 126:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/25\">",
"      Bonadonna P, Perbellini O, Passalacqua G, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009; 123:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/26\">",
"      Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992; 327:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/27\">",
"      Yunginger JW, Nelson DR, Squillace DL, et al. Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 1991; 36:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/28\">",
"      Shen Y, Li L, Grant J, et al. Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006. Forensic Sci Int 2009; 186:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/29\">",
"      Mayer DE, Krauskopf A, Hemmer W, et al. Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Sci Int 2011; 212:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/30\">",
"      Randall B, Butts J, Halsey JF. Elevated postmortem tryptase in the absence of anaphylaxis. J Forensic Sci 1995; 40:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/31\">",
"      Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol 1991; 88:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/32\">",
"      Fischer AR, Rosenberg MA, Lilly CM, et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 1994; 94:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/33\">",
"      Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy 1996; 26:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/34\">",
"      Silvers WS, Essember LJ, Williams PB, et al. Anaphylaxis due to Diclofenac Sodium (Voltaren): Evidence of mast cell mediator release. Immunol Allergy Pract 1991; 13:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/35\">",
"      The FO, Bennink RJ, Ankum WM, et al. Intestinal handling-induced mast cell activation and inflammation in human postoperative ileus. Gut 2008; 57:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/36\">",
"      Platt MS, Yunginger JW, Sekula-Perlman A, et al. Involvement of mast cells in sudden infant death syndrome. J Allergy Clin Immunol 1994; 94:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/37\">",
"      Schwartz HJ, Yunginger JW, Schwartz LB. Is unrecognized anaphylaxis a cause of sudden unexpected death? Clin Exp Allergy 1995; 25:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/38\">",
"      Valent P, Sperr WR, Schwartz LB, Horny HP. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol 2004; 114:3.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/cdrh_docs/reviews/K103039.pdf (Accessed on September 13, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/40\">",
"      Sperr WR, Jordan JH, Baghestanian M, et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001; 98:2200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/41\">",
"      Sperr WR, Stehberger B, Wimazal F, et al. Serum tryptase measurements in patients with myelodysplastic syndromes. Leuk Lymphoma 2002; 43:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/42\">",
"      Klion AD, Noel P, Akin C, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 2003; 101:4660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/43\">",
"      Brezin AL, Brezin JH, Raible DG, et al. Elevated stem cell factor and a-protryptase levels in uremia. J Allergy Clin Immunol 1999; 103:S233 (Abstract).",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/44\">",
"      Dugas-Breit S, Sch&ouml;pf P, Dugas M, et al. Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus. J Dtsch Dermatol Ges 2005; 3:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/45\">",
"      Cooper PJ, Schwartz LB, Irani AM, et al. Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin. J Infect Dis 2002; 186:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/46\">",
"      Costa JJ, Demetri GD, Harrist TJ, et al. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996; 183:2681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/47\">",
"      Kanthawatana S, Carias K, Arnaout R, et al. The potential clinical utility of serum alpha-protryptase levels. J Allergy Clin Immunol 1999; 103:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/48\">",
"      Sargur R, Cowley D, Murng S, et al. Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay. Clin Exp Immunol 2011; 163:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/49\">",
"      van Toorenenbergen AW, van Daele PL, Boonstra JG. False-elevated serum tryptase assay result caused by heterophilic antibodies. J Allergy Clin Immunol 2005; 116:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/50\">",
"      van Toorenenbergen AW, Hooijkaas H, Heerenbrink GK, Dufour-van den Goorbergh DM. Heterophilic antibody interference in a tryptase immunoassay. Clin Biochem 2008; 41:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/51\">",
"      Laroche D, Vergnaud MC, Dubois F, et al. Plasma histamine and tryptase during anaphylactoid reactions. Agents Actions 1992; 36:C201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/52\">",
"      Stephan V, Zimmermann A, K&uuml;hr J, Urbanek R. Determination of N-methylhistamine in urine as an indicator of histamine release in immediate allergic reactions. J Allergy Clin Immunol 1990; 86:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/53\">",
"      Takeda J, Ueda E, Takahashi J, Fukushima K. Plasma N-methylhistamine concentration as an indicator of histamine release by intravenous d-tubocurarine in humans: preliminary study in five patients by radioimmunoassay kits. Anesth Analg 1995; 80:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/54\">",
"      Schulze S, Niggemann B, Savaser AN, Wahn U. Diurnal variation of urinary histamine and 1-methylhistamine excretion in healthy children. Allergy 1992; 47:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/55\">",
"      Oosting E, Keyzer JJ, Wolthers BG, Scholtis RJ. Age dependent normal values of histamine and histamine metabolites in human urine. Agents Actions 1988; 23:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/56\">",
"      Laroche D, Dubois F, Lefran&ccedil;ois C, et al. [Early biological markers of anaphylactoid reactions occurring during anesthesia]. Ann Fr Anesth Reanim 1992; 11:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/57\">",
"      Keyzer JJ, van Saene HK, van den Berg GA, Wolthers BG. Influence of decontamination of the digestive tract on the urinary excretion of histamine and some of its metabolites. Agents Actions 1984; 15:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/58\">",
"      Keyzer JJ, Breukelman H, Wolthers BG, et al. Urinary excretion of histamine and some of its metabolites in man: influence of the diet. Agents Actions 1984; 15:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/59\">",
"      Oosting E, Keyzer JJ, Wolthers BG. Correlation between urinary levels of histamine metabolites in 24-hour urine and morning urine samples of man: influence of histamine-rich food. Agents Actions 1989; 27:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/60\">",
"      Morrow JD, Margolies GR, Rowland J, Roberts LJ 2nd. Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med 1991; 324:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/61\">",
"      Hershko AY, Dranitzki Z, Ulmanski R, et al. Constitutive hyperhistaminaemia: a possible mechanism for recurrent anaphylaxis. Scand J Clin Lab Invest 2001; 61:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/62\">",
"      Roberts LJ 2nd, Sweetman BJ, Lewis RA, et al. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 1980; 303:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/63\">",
"      Awad JA, Morrow JD, Roberts LJ 2nd. Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. J Allergy Clin Immunol 1994; 93:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/64\">",
"      Morrow JD, Guzzo C, Lazarus G, et al. Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2. J Invest Dermatol 1995; 104:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/65\">",
"      Butterfield JH, Weiler CR. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production. Int Arch Allergy Immunol 2008; 147:338.",
"     </a>",
"    </li>",
"    <li>",
"     Assays of urinary prostaglandins are available throught Mayo Medical Laboratories. www.mayomedicallaboratories.com (Accessed on June 14, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/67\">",
"      Schwartz LB. Analysis of MC(T) and MC(TC) mast cells in tissue. Methods Mol Biol 2006; 315:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/68\">",
"      Nishio H, Takai S, Miyazaki M, et al. Usefulness of serum mast cell-specific chymase levels for postmortem diagnosis of anaphylaxis. Int J Legal Med 2005; 119:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/69\">",
"      Zhou X, Buckley MG, Lau LC, et al. Mast Cell Carboxypeptidase as a New Clinical Marker for Anaphylaxis. J Allergy Clin Immunol 2006; 117:S85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/70\">",
"      Brown TA, Whitworth HS, Zhou XY, et al. Mast cell carboxypeptidase as a confirmatory and predictive marker in allergic reactions to drugs. J Allergy Clin Immunol 2011; 127:Abstract 143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/54/40809/abstract/71\">",
"      Ono E, Taniguchi M, Mita H, et al. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Clin Exp Allergy 2009; 39:72.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 389 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-564C5304BD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40809=[""].join("\n");
var outline_f39_54_40809=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2357974\">",
"      Available tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Time course of mediator release",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TRYPTASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Forms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Assays",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Proper collection of samples",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Normal levels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Elevations in anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1045841\">",
"      - Relationship to hypotension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1045864\">",
"      - Food-induced anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Fatal anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Diagnostic specificity of postmortem levels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Conclusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Elevations of tryptase in nonanaphylactic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Systemic mastocytosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1046138\">",
"      - Causes of false positive elevations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      HISTAMINE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Elevations during anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Histamine metabolites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Assays and collection of samples",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Other causes of elevated histamine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5038436\">",
"      PROSTAGLANDIN AND METABOLITES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      POSSIBLE FUTURE TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Chymase and carboxypeptidase A3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5038668\">",
"      Sulfidopeptide leukotrienes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      TESTS FOR CONDITIONS MIMICKING ANAPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/389\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/389|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/13/43231\" title=\"figure 1\">",
"      Tryptase levels examples",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/389|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/28/16844\" title=\"table 1\">",
"      Tests for anaphylaxis mediators",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/8/21644\" title=\"table 2\">",
"      Tryptase and histamine collection instructions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/24/38283\" title=\"table 3\">",
"      Tryptase in Ana vs masto",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/55/8059\" title=\"table 4\">",
"      Lab eval flushing",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/11/9401?source=related_link\">",
"      Anaphylaxis: Confirming the diagnosis and determining the trigger(s)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/8/11400?source=related_link\">",
"      Diagnosis of the carcinoid syndrome and tumor localization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/62/38888?source=related_link\">",
"      Differential diagnosis of anaphylaxis in children and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/13/18650?source=related_link\">",
"      Evaluation and diagnosis of mastocytosis (cutaneous and systemic)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/13/1241?source=related_link\">",
"      Fatal anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/22/44393?source=related_link\">",
"      Mast cells: Development, identification, and physiologic roles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=related_link\">",
"      Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/19/1336?source=related_link\">",
"      NSAIDs: Mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/22/44391?source=related_link\">",
"      Overview of in vitro allergy tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32633?source=related_link\">",
"      Overview of skin testing for allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/21/18778?source=related_link\">",
"      Pathophysiology of anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/57/15250?source=related_link\">",
"      Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/14/41186?source=related_link\">",
"      Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/61/16346?source=related_link\">",
"      Seafood allergies: Fish and shellfish",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/59/16311?source=related_link\">",
"      The VIPoma syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_54_40810="Acute anterior MI tutorial";
var content_f39_54_40810=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1245px;\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Acute transmural anterior wall myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 146px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    ST elevation in some or all of the precordial leads is characteristic of an acute anterior wall infarct.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40810=[""].join("\n");
var outline_f39_54_40810=null;
var title_f39_54_40811="LOS and inhalation injury";
var content_f39_54_40811=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F81666&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F81666&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Mean length of hospital stay based on age and associated inhalation injury with burn",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Age group",
"      </td>",
"      <td class=\"subtitle1\">",
"       Mean LOS* burn only",
"      </td>",
"      <td class=\"subtitle1\">",
"       Mean LOS burn with inhalation injury",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       0 - 0.9",
"      </td>",
"      <td>",
"       5.8",
"      </td>",
"      <td>",
"       28.1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       1.0 - 1.9",
"      </td>",
"      <td>",
"       5.1",
"      </td>",
"      <td>",
"       33.7",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2.0 - 4.9",
"      </td>",
"      <td>",
"       6.9",
"      </td>",
"      <td>",
"       31.4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       5.0 - 15.9",
"      </td>",
"      <td>",
"       7.7",
"      </td>",
"      <td>",
"       32.8",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       16.0 - 19.9",
"      </td>",
"      <td>",
"       6.8",
"      </td>",
"      <td>",
"       25.1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       20.0 - 29.9",
"      </td>",
"      <td>",
"       7.6",
"      </td>",
"      <td>",
"       26.1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       30.0 - 39.9",
"      </td>",
"      <td>",
"       7.9",
"      </td>",
"      <td>",
"       25.6",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       40.0 - 49.9",
"      </td>",
"      <td>",
"       9.0",
"      </td>",
"      <td>",
"       25.8",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       50.0 - 59.9",
"      </td>",
"      <td>",
"       10.4",
"      </td>",
"      <td>",
"       25.4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       60.0 - 69.9",
"      </td>",
"      <td>",
"       12.2",
"      </td>",
"      <td>",
"       22.9",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       70.0 - 79.9",
"      </td>",
"      <td>",
"       14.4",
"      </td>",
"      <td>",
"       19.6",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       80+",
"      </td>",
"      <td>",
"       14.2",
"      </td>",
"      <td>",
"       18.6",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * LOS: length of hospital stay in days.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: American Burn Association. National Burn Repository, Version 5.0 2009. Available online at: www.ameriburn.org/2009NBRAnnualReport.pdf",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40811=[""].join("\n");
var outline_f39_54_40811=null;
var title_f39_54_40812="Screening under fifty years";
var content_f39_54_40812=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F72728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F72728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Screening and prevention, adults younger than 50 years",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Priority health problem",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effective preventive intervention(s)",
"       </td>",
"       <td class=\"subtitle1\">",
"        UpToDate topics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cervical cancer",
"       </td>",
"       <td>",
"        Screening with Pap smear for women ages 21 to 65; every three years if sexually active and if previously normal results",
"       </td>",
"       <td>",
"        Screening for cervical cancer: Clinical recommendations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Depression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        Brief screening; follow-up if positive; treatment if needed",
"       </td>",
"       <td>",
"        Depression in adults: Pathophysiology, clinical manifestations, and diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Motor vehicle crashes",
"       </td>",
"       <td>",
"        Screen for alcohol misuse; brief counseling with follow-up if positive",
"       </td>",
"       <td>",
"        Screening for and diagnosis of patients with alcohol problems",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Domestic violence",
"       </td>",
"       <td>",
"        Be alert for early signs and symptoms",
"       </td>",
"       <td>",
"        Diagnosis, screening and counseling for domestic violence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Lifestyle-related problems",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Obesity",
"       </td>",
"       <td rowspan=\"2\">",
"        Discuss problem with patient; refer obese and physically inactive people to intensive, multidisciplinary programs",
"       </td>",
"       <td>",
"        Overview of therapy for obesity in adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Physical activity",
"       </td>",
"       <td>",
"        Overview of the risks and benefits of exercise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Sexually-transmitted infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chlamydia",
"       </td>",
"       <td>",
"        Screen sexually active women ages 15 to 25 for chlamydia; plus older women who have had a previous infection",
"       </td>",
"       <td>",
"        Screening for Chlamydia trachomatis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gonorrhea",
"       </td>",
"       <td>",
"        Screen young, sexually active women who live in high-risk areas for gonorrhea",
"       </td>",
"       <td>",
"        Approach to sexually transmitted diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        HIV",
"       </td>",
"       <td>",
"        Screen people with either an individual risk factor or who receive health care in a high-prevalence setting",
"       </td>",
"       <td>",
"        Serologic tests for the diagnosis of HIV infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Substance abuse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tobacco",
"       </td>",
"       <td>",
"        5 A's*, offer nicotine replacement and bupropion, follow-up",
"       </td>",
"       <td>",
"        Overview of smoking cessation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alcohol",
"       </td>",
"       <td>",
"        Screen for alcohol misuse; brief counseling with follow-up if positive",
"       </td>",
"       <td>",
"        Screening for and diagnosis of patients with alcohol problems",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Ask, advise, assess, assist, arrange.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40812=[""].join("\n");
var outline_f39_54_40812=null;
var title_f39_54_40813="Contents: Pain disorders in rheumatology";
var content_f39_54_40813=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?3/39/3710\">",
"       Rheumatology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pain disorders in rheumatology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pain disorders in rheumatology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Fibromyalgia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/55/8056\">",
"           Clinical manifestations and diagnosis of fibromyalgia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/49/35608\">",
"           Differential diagnosis of fibromyalgia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/15/14586\">",
"           Initial treatment of fibromyalgia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/19/31031\">",
"           Pathogenesis of fibromyalgia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/41/5786\">",
"           Treatment of fibromyalgia in adults not responsive to initial therapies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Musculoskeletal pain",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/7/9335\">",
"           Clinical evaluation of musculoskeletal chest pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/9/2201\">",
"           Major causes of musculoskeletal chest pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/1/7194\">",
"           Temporomandibular joint dysfunction syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/29/5592\">",
"           Treatment of musculoskeletal chest pain",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Reflex sympathetic dystrophy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/37/32344\">",
"           Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/62/6122\">",
"           Prevention and management of complex regional pain syndrome in adults",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-AF934F3926-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f39_54_40813=[""].join("\n");
var outline_f39_54_40813=null;
var title_f39_54_40814="Simvastatin and atherosclerosis";
var content_f39_54_40814=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F76764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F76764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 491px\">",
"   <div class=\"ttl\">",
"    Simvastatin retards progression of atherosclerosis in vasculature",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 471px; height: 356px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among 4444 patients with established coronary heart disease who were entered into the Scandinavian Simvastatin Survival Study, therapy with simvastatin, compared to placebo, significantly reduced the incidence of intermittent claudication, the number of patients with a new carotid bruit, the incidence of new or worsening angina pectoris, and the incidence of cerbrovascular events.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Pedersen, TR, Kjekshus, J, Pyorala, K, et al. Am J Cardiol 1998; 81:333.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40814=[""].join("\n");
var outline_f39_54_40814=null;
var title_f39_54_40815="Chest wall extension MRI II";
var content_f39_54_40815=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F67306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F67306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lung carcinoma with chest wall invasion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 310px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sagittal T1-weighted section shows that the large tumor in the previous image is invading the posteroapical chest wall (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_54_40815=[""].join("\n");
var outline_f39_54_40815=null;
         